WO2016041505A1 - Tedizolid phosphate, intermediate and preparation method thereof - Google Patents

Tedizolid phosphate, intermediate and preparation method thereof Download PDF

Info

Publication number
WO2016041505A1
WO2016041505A1 PCT/CN2015/089820 CN2015089820W WO2016041505A1 WO 2016041505 A1 WO2016041505 A1 WO 2016041505A1 CN 2015089820 W CN2015089820 W CN 2015089820W WO 2016041505 A1 WO2016041505 A1 WO 2016041505A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
formula
group
sodium
potassium
Prior art date
Application number
PCT/CN2015/089820
Other languages
French (fr)
Chinese (zh)
Inventor
朱益忠
张喜全
刘飞
顾红梅
朱波
汤剑秋
汤松
王路路
Original Assignee
正大天晴药业集团股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201410476920.0A external-priority patent/CN105418678B/en
Priority claimed from CN201410545318.8A external-priority patent/CN105566392B/en
Priority claimed from CN201410546241.6A external-priority patent/CN105503955B/en
Priority claimed from CN201510014000.1A external-priority patent/CN105837633B/en
Application filed by 正大天晴药业集团股份有限公司 filed Critical 正大天晴药业集团股份有限公司
Publication of WO2016041505A1 publication Critical patent/WO2016041505A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system

Definitions

  • the invention belongs to the field of medicinal chemical industry, and in particular relates to tertidazole phosphate, an intermediate thereof and a novel preparation method thereof.
  • the first step of the route uses a toxic organotin reagent
  • the second step of the condensation reaction produces the key intermediate (R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridine-5-
  • the yield of 3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one is as low as 26%
  • the third step is to prepare (R)-[3-(4-(2-(2-) Methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-2-oxo-5-oxazolidine] bis(tetrabutyl ester) methyl phosphate is carried out at -78 ° C.
  • the reaction time is long, and the last step requires the use of trifluoroacetic acid having a pungent odor and strong corrosiveness. Therefore, the total yield of the route is low, the production cost is high, the reaction conditions are harsh, the production cycle is long, and the reagents used are toxic or irritating, corrosive, and are not suitable for industrial production.
  • the route is long by the starting material synthesis reaction route, wherein the second step of the boronation reaction needs to be carried out at a low temperature of -72 ° C and the yield of the obtained product 4-(benzyloxycarbonylamino)-2-fluorobenzeneboronic acid is only 66%. And it is very impure.
  • the fourth step of the ring-forming reaction is cumbersome and the reaction time is long.
  • the final step of phosphorylation uses the highly toxic fuming liquid phosphorus oxychloride. Therefore, the route is not suitable for industrial mass production.
  • the method for synthesizing the tertidamine phosphate disclosed in the prior art has many drawbacks, and therefore a new method for preparing tertazolam phosphate is still required.
  • the invention relates to a novel process for the preparation of terbutazol phosphate (a compound of formula I).
  • the invention relates to an intermediate compound of formula VII of a compound of formula I and a process for the preparation thereof.
  • the invention relates to a process for the preparation of a compound of formula V of the compound of formula I.
  • the invention relates to a process for the preparation of a compound of formula IX of the compound of formula I.
  • the invention relates to a process for the preparation of a compound of formula X of the compound of formula I.
  • the present invention provides a process for the preparation of a compound of formula I, which comprises reacting a compound of formula VII with a benzyl group as follows:
  • the benzyl removal reaction can be carried out in the presence of a catalyst and a hydrogen source.
  • the catalyst is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
  • the hydrogen source is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
  • the preparation of the compound of the formula I can be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, Composition of valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO a solvent or a mixed solvent of several solvents in the group, preferably a solvent selected from the group consisting of ethyl acetate, butyl acetate and C 1 -C 8 alcohol or several solvents
  • the mixed solvent is most preferably a solvent selected from the group consisting of ethyl acetate
  • the benzyl removal reaction can be carried out in the presence of trifluoroacetic acid.
  • the preparation of the compound of the formula I can be carried out by selecting a suitable reaction solvent selected from the group consisting of dichloromethane, chloroform, carbon tetrachloride, water, C 1 -C 8 alcohol, 1,4. - dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene
  • the preparation of the compound of formula I further comprises the step of purifying the reaction product with an organic solvent including, but not limited to, petroleum ether, diethyl ether, diisopropyl ether, cyclohexane, dichloromethane, chloroform.
  • an organic solvent including, but not limited to, petroleum ether, diethyl ether, diisopropyl ether, cyclohexane, dichloromethane, chloroform.
  • the method for preparing the compound of the formula I further comprises: reacting the compound of the formula V and the compound of the formula VI in the presence of a catalyst and an oxidizing agent to prepare the compound of the VII,
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or, R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy substituted benzyl, preferably R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl,
  • the catalyst is selected from the group consisting of 1H-tetrazole or Preferred is 1H-tetrazole,
  • the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
  • reaction solvent is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, and a solvent or a mixed solvent of several solvents in a group consisting of ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO, preferably For methylene chloride,
  • the compound of the formula VI is preferably dibenzyl diisopropylaminophosphite.
  • the method for preparing the compound of formula I further comprises: preparing the compound of formula V according to the following steps:
  • step (1) the product of step (1) is reacted with a compound of formula IV in the presence of a palladium catalyst and a base,
  • X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br,
  • the borating agent of the step (1) is selected from the group consisting of pinacol borate, Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester,
  • the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
  • said base in step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium,
  • the palladium catalyst of the step (2) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
  • the base of the step (2) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide and lithium diisopropylamide from C 1 -C 8 .
  • One or more of the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine Preferred is potassium acetate.
  • the method for preparing the compound of the formula I further comprises: preparing the compound of the formula V by reacting the compound of the formula X with a compound of the formula III in the presence of a palladium catalyst and a base,
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
  • the compound of formula III is preferably (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula VIII),
  • the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
  • the base is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide from C 1 -C 8
  • the reaction solvent is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, a solvent or a mixture of several solvents in the group consisting of ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO, and NMP Solvent,
  • the preparation of the compound of the formula V is carried out under the protection of N 2 or Ar.
  • the method for preparing the compound of formula I further comprises: reacting a compound of formula IX with a compound of formula X in the presence of a palladium catalyst and a base to prepare the compound of formula VII,
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
  • the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
  • the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide,
  • the compound of the formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methylphosphonic acid bis(benzyl ester).
  • the method for preparing the compound of the formula I further comprises: reacting the compound of the formula III and the compound of the formula VI in the presence of a catalyst and an oxidizing agent to prepare the compound of the formula IX,
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy-substituted benzyl group, preferably at the same time R 1 and R 2 is isopropyl or ethyl, most preferably R 1 and R 2 simultaneously isopropyl,
  • the catalyst is selected from the group consisting of 1H-tetrazole or Preferred is 1H-tetrazole,
  • the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
  • the compound of formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester), a compound of formula III Preferred is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one.
  • the method for preparing the compound of the formula I further comprises: reacting the compound of the formula IV with a borating reagent in the presence of a palladium catalyst and a base to prepare the compound of the formula X,
  • X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
  • the borating agent is selected from the group consisting of pinacol borate, Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester,
  • the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
  • the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide,
  • the method of preparing a compound of formula I comprises:
  • a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
  • the compound of formula IX is (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester) (Formula XII),
  • the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
  • the base of the step (1) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide and lithium diisopropylamide from C 1 -C 8 .
  • One or more of the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediaminekind preferably sodium carbonate or potassium carbonate, most preferably sodium carbonate,
  • the step (1) can be carried out by selecting a suitable reaction solvent according to requirements, including but not limited to water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid Butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC a solvent in a group consisting of DMSO and NMP or a mixed solvent of several solvents.
  • the reaction solvent is a mixed solvent of 1,4-dioxane and water.
  • reaction of step (1) can be carried out under the protection of N 2 or Ar.
  • the catalyst of the step (2) is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
  • the hydrogen source of the step (2) is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
  • the step (2) can be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, Butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and a solvent in a group consisting of DMSO or a mixed solvent of several solvents, preferably a solvent or a group selected from the group consisting of ethyl acetate, butyl acetate, and C 1 -C 8 alcohol
  • the mixed solvent of the solvent is most preferably a solvent selected from the group consisting of ethyl acetate,
  • reaction can be carried out under the protection of N 2 or Ar.
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the compound of formula IX is (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester) (Formula XII), the compound of formula III is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula XI),
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C An alkyl group of 4 or a C 1 -C 4 alkoxy-substituted benzyl group.
  • R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
  • the catalyst is selected from the group consisting of 1H-tetrazole or It is preferably 1H-tetrazole.
  • the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid (mCPBA).
  • mCPBA m-chloroperoxybenzoic acid
  • TBHP t-butyl hydroperoxide
  • the preparation of the compound of the formula IX can be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, Composition of valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO
  • a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, Composition of valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentan
  • the compound of formula VI is dibenzylaminodiphosphite (formula II),
  • the method comprises: reacting a compound of the formula IV with a borating reagent in the presence of a palladium catalyst and a base,
  • X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the compound of formula IV is 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (Formula XIII).
  • the borating agent is selected from the group consisting of pinacol borate Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester.
  • the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
  • the base is selected from the C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide,
  • One or more of the group consisting of potassium, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine is preferably potassium acetate.
  • the preparation of the compound of the formula X can be carried out by selecting a suitable solvent, including but not limited to water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, pentane. Acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO and NMP
  • a suitable solvent including but not limited to water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, pentane. Acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ket
  • the method for preparing a compound of formula I comprises:
  • step i) reacting the product of step i) with a compound of formula IV in the presence of a palladium catalyst and a base to prepare a compound of formula V,
  • a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
  • X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 - An alkyl group of C 4 or a C 1 -C 4 alkoxy-substituted benzyl group.
  • R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
  • the boriding agent of step i) is selected from the group consisting of pinacol borate Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester.
  • the palladium catalyst of the step i) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
  • the base of the step i) is selected from the group consisting of C 1 -C 8 sodium alkoxide, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, potassium hydroxide,
  • One or more of sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine or ethylenediamine is preferably potassium acetate.
  • the palladium catalyst of the step ii) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
  • the base of the step ii) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, potassium hydroxide from C 1 -C 8 .
  • the catalyst of step iii) is 1H-tetrazole or It is preferably 1H-tetrazole.
  • the oxidizing agent of step iii) is selected from m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid ( mCPBA).
  • mCPBA m-chloroperoxybenzoic acid
  • TBHP t-butyl hydroperoxide
  • mCPBA m-chloroperoxybenzoic acid
  • the catalyst of step iv) is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
  • the hydrogen source of step iv) is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
  • the preparation method of the compound of formula I includes:
  • a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
  • X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 - An alkyl group of C 4 or a C 1 -C 4 alkoxy-substituted benzyl group.
  • R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
  • the catalyst of step i) is 1H-tetrazole or It is preferably 1H-tetrazole.
  • the oxidizing agent of step i) is selected from m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid ( mCPBA).
  • mCPBA m-chloroperoxybenzoic acid
  • TBHP t-butyl hydroperoxide
  • the boriding agent of step ii) is selected from the group consisting of pinacol borate Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester.
  • the palladium catalyst of the step ii) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
  • Said step ii) is a base selected from the C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, hydroxide
  • the palladium catalyst of the step iii) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
  • Said step iii) is a base selected from the C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, hydroxide
  • the catalyst of step iv) is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
  • the hydrogen source of step iv) is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
  • the method for preparing a compound of formula I comprises:
  • a compound of the formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of the formula I,
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the compound of formula III is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula VIII),
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or tert-butyl; or R 1 and R 2 are each independently selected a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C 4 Alkyl or C 1 -C 4 alkoxy-substituted benzyl.
  • R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
  • the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex.
  • said base in step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide,
  • the step (1) may be carried out by selecting a suitable reaction solvent according to requirements, including but not limited to water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyl Acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO A solvent or a mixed solvent of several solvents in a group consisting of NMP.
  • the reaction solvent of step (1) is DMSO.
  • step (1) reaction can be carried out under the protection of N 2 or Ar.
  • the catalyst of the step (2) is selected from 1H-tetrazole or It is preferably 1H-tetrazole.
  • the oxidizing agent of the step (2) is selected from m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxy Benzoic acid (mCPBA).
  • mCPBA m-chloroperoxybenzoic acid
  • TBHP t-butyl hydroperoxide
  • mCPBA m-chloroperoxy Benzoic acid
  • the step (2) may be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid. , valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO A solvent or a mixed solvent of several solvents in the composition group.
  • the reaction solvent is dichloromethane.
  • the compound of formula VI is dibenzylaminodiphosphite (formula II),
  • the catalyst of the step (3) is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
  • the hydrogen source of the step (3) is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
  • the step (3) may be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid. , valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO
  • the mixed solvent is most preferably a solvent selected from the group consisting of ethyl acetate, methanol and
  • the method for preparing a compound of formula I comprises:
  • a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
  • X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 - An alkyl group of C 4 or a C 1 -C 4 alkoxy-substituted benzyl group.
  • R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
  • the boriding agent of step i) is selected from the group consisting of pinacol borate Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester.
  • the palladium catalyst of the step i) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
  • a base selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, hydroxide
  • a base selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, hydroxide
  • the palladium catalyst of the step ii) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
  • Said step ii) is a base selected from the C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, hydroxide
  • the catalyst of step iii) is 1H-tetrazole or It is preferably 1H-tetrazole.
  • the oxidizing agent of step iii) is selected from m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid ( mCPBA).
  • mCPBA m-chloroperoxybenzoic acid
  • TBHP t-butyl hydroperoxide
  • mCPBA m-chloroperoxybenzoic acid
  • the catalyst of step iv) is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
  • the hydrogen source of step iv) is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
  • the method for preparing a compound of formula I comprises:
  • step i) reacting the product of step i) with a compound of formula IV in the presence of a palladium catalyst and a base to prepare a compound of formula V,
  • X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 - An alkyl group of C 4 or a C 1 -C 4 alkoxy-substituted benzyl group.
  • R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
  • the boriding agent of step i) is selected from the group consisting of pinacol borate Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester.
  • the palladium catalyst of the step i) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
  • the base of the step i) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, potassium hydroxide from C 1 -C 8 .
  • the palladium catalyst of the step ii) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
  • the base of the step ii) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, potassium hydroxide from C 1 -C 8 .
  • the catalyst of step iii) is 1H-tetrazole or It is preferably 1H-tetrazole.
  • the oxidizing agent of step iii) is selected from m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid ( mCPBA).
  • mCPBA m-chloroperoxybenzoic acid
  • TBHP t-butyl hydroperoxide
  • mCPBA m-chloroperoxybenzoic acid
  • the compound of the formula VI in the present embodiment can be obtained commercially, or can be produced by a method of the prior art, for example, by the following method.
  • the compound of formula II can be obtained commercially, or can be prepared by the following method.
  • the compound of the formula II, the compound of the formula VI, the compound of the formula IX, the compound of the formula VII or the compound of the formula XII of the present invention also encompasses a compound in which the benzene ring on the benzyl group is mono- or polysubstituted, as long as the above reaction can be carried out.
  • Substituents include, but are not limited to, halogen, hydroxy, amino, cyano, carboxy, sulfonyl, decyl, trifluoromethyl, nitro, phenyl, benzyl, benzyloxy, pyridyl, piperidinyl, hydroxymethyl group, hydroxyethyl, hydroxypropyl, optionally substituted with halogen or C 1 -C 6 alkoxy-substituted C 1 -C 6 alkyl, optionally substituted by halogen or C 1 -C 6 alkoxy group, a C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkoxycarbonyl, C 1 -C 6 alkylcarbonyl, C 1 -C 6 alkylamino, C 1 -C 6 alkane Alkylcarbonyloxy, C 3 -C 7 cycloalkyl, C 3 -C 7 cyclo
  • the palladium catalyst of the present invention may also be various palladium complex compounds prepared from various palladium catalysts and ligands including, but not limited to, PCy 3 , AsPh 3 , n-Bu 3 P, (MeO) 3 P, Ph 2 P(CH 2 ) 2 PPh 2 (dppe) or Ph 2 P(CH 2 ) 3 PPh 2 (dppp).
  • C 1 -C n as used herein includes C 1 -C 2 , C 1 -C 3 , ... C 1 -C n .
  • C 1 -C 8 means that the moiety has 1-8 carbon atoms, that is, contains 1 carbon atom, 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms. , 6 carbon atoms, 7 carbon atoms or 8 carbon atoms, and C 1 -C 2 and C 3 -C 7 are also the same.
  • a sodium alkoxide of C 1 -C 8 means a sodium alkoxide having from 1 to 8 carbon atoms, that is, the sodium alkoxide contains one carbon atom, two carbon atoms, three carbon atoms, 4 carbon atoms, 5 carbon atoms, 6 carbon atoms, 7 carbon atoms or 8 carbon atoms; and, for example, "C 1 -C 6 alkyl” means an alkyl group having 1 to 6 carbon atoms, that is, The alkyl group contains 1 carbon atom, 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, more specifically, for example, "C 1 -C 4 alkyl group” It means an alkyl group having 1 to 4 carbon atoms, that is, the alkyl group is selected from the group consisting of methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-but
  • the "dppf" described in the present invention is 1,1'-bis(diphenylphosphino)ferrocene.
  • the "dba” described in the present invention is dibenzylideneacetone.
  • PCy 3 described in the present invention is tricyclohexylphosphine.
  • the "dppe” described in the present invention is 1,2-bis(diphenylphosphino)ethane.
  • the "dppp” described in the present invention is 1,3-bis(diphenylphosphino)propane.
  • the present invention provides a compound of formula VII,
  • the invention also provides a process for the preparation of a compound of formula VII.
  • the method comprises: reacting a compound of formula V with a compound of formula VI in the presence of a catalyst, an oxidizing agent,
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C An alkyl group of 4 or a C 1 -C 4 alkoxy-substituted benzyl group.
  • R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
  • the catalyst is selected from the group consisting of 1H-tetrazole or It is preferably 1H-tetrazole.
  • the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid (mCPBA).
  • mCPBA m-chloroperoxybenzoic acid
  • TBHP t-butyl hydroperoxide
  • the preparation of the compound of the formula VII can be carried out by selecting a suitable reaction solvent selected from the group consisting of water, a C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid. a group consisting of acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO A solvent or a mixed solvent of several solvents.
  • the reaction solvent is dichloromethane.
  • the compound of formula VI is dibenzylaminodiphosphite (formula II),
  • the compound of the above formula V can be produced by any one of the following two production methods.
  • the method comprises:
  • step (1) the product of step (1) is reacted with a compound of formula IV in the presence of a palladium catalyst and a base,
  • X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the compound of formula III is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one.
  • the compound of formula IV is 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine.
  • the borating agent of the step (1) is selected from the group consisting of pinacol borate Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester.
  • the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex Things.
  • the palladium catalyst of the step (2) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex Things.
  • the base of the step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, and hydroxide.
  • One or more of the group consisting of potassium, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine is preferably potassium acetate.
  • Said base of step (2) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide,
  • One or more of the group consisting of potassium, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine is preferably cesium carbonate.
  • the preparation of the compound of the formula V can be carried out by selecting a suitable reaction solvent including, but not limited to, water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid. , valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO and A solvent of a group consisting of NMP or a mixed solvent of several solvents.
  • the solvent of step (1) is DMSO
  • the solvent of step (2) is a mixed solvent of 1,4-dioxane and water.
  • step (1) and step (2) can be carried out under the protection of N 2 or argon.
  • the method comprises: reacting a compound of the formula X with a compound of the formula III in the presence of a palladium catalyst and a base to prepare a compound of the formula V,
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the compound of formula III is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula VIII),
  • the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 is preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
  • the base is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide (LDA), hydrogen from C 1 -C 8 .
  • the preparation of the compound of the formula V can be carried out by selecting a suitable reaction solvent including, but not limited to, water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid. , valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO and A solvent in a group consisting of NMP or a mixed solvent of several solvents.
  • the solvent of step (1) is DMSO
  • the solvent of step (2) is a mixed solvent of 1,4-dioxane and water.
  • the preparation of the compound of formula V can be carried out under the protection of N 2 or Ar.
  • a second embodiment of the process for the preparation of a compound of formula VII which comprises reacting a compound of formula IX with a compound of formula X in the presence of a palladium catalyst and a base to prepare a compound of formula VII,
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the compound of formula IX is (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester) (Formula XII),
  • the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 is preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
  • the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide,
  • the preparation of the compound of the formula VII can be carried out by selecting a suitable reaction solvent including, but not limited to, water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, and the like.
  • a suitable reaction solvent including, but not limited to, water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, and the like.
  • the reaction solvent is a mixed solvent
  • the preparation of the compound of formula VII can be carried out under the protection of N 2 or Ar.
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the compound of formula IX is (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester) (Formula XII), the compound of formula III is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula XI),
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C An alkyl group of 4 or a C 1 -C 4 alkoxy-substituted benzyl group.
  • R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
  • the catalyst is selected from the group consisting of 1H-tetrazole or It is preferably 1H-tetrazole.
  • the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid (mCPBA).
  • mCPBA m-chloroperoxybenzoic acid
  • TBHP t-butyl hydroperoxide
  • the preparation of the compound of the formula IX can be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, Composition of valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO
  • a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, Composition of valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentan
  • the compound of formula VI is dibenzylaminodiphosphite (formula II),
  • a method for preparing the above compound of the formula X may include: reacting the compound of the formula IV with a borating reagent in the presence of a palladium catalyst and a base,
  • X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the compound of formula IV is 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (Formula XIII).
  • the borating agent is selected from the group consisting of pinacol borate Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester.
  • the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
  • the base is selected from the C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide,
  • One or more of the group consisting of potassium, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine is preferably potassium acetate.
  • the preparation of the compound of the formula X can be carried out by selecting a suitable solvent including, but not limited to, water, a C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, and the like.
  • a suitable solvent including, but not limited to, water, a C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, and the like.
  • Valeric acid acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO and NMP
  • the reaction solvent is DMSO.
  • the invention relates to a process for the preparation of a compound of formula V of the compound of formula I.
  • the preparation method of the intermediate compound of formula V comprises: preparing the compound of formula V according to the following steps:
  • step (1) the product of step (1) is reacted with a compound of formula IV in the presence of a palladium catalyst and a base,
  • X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the borating agent of the step (1) is selected from the group consisting of pinacol borate, Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester.
  • the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex.
  • said base in step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium.
  • the palladium catalyst of the step (2) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex.
  • the base of the step (2) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide and lithium diisopropylamide from C 1 -C 8 .
  • One or more of the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine Preferred is potassium acetate.
  • the preparation method of the intermediate formula V compound comprises: preparing the compound of the formula V by reacting the compound of the formula X with the compound of the formula III in the presence of a palladium catalyst and a base,
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the compound of formula III is preferably (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula VIII),
  • the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 is preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
  • the base is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide from C 1 -C 8
  • the solvent for the reaction is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, and ring.
  • the preparation of the compound of the formula V is carried out under the protection of N 2 or Ar.
  • the present invention relates to a process for the preparation of a compound of the formula IX of the compound of the formula I, which comprises reacting a compound of the formula III and a compound of the formula VI in the presence of a catalyst and an oxidizing agent to prepare the compound of the formula IX,
  • X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
  • R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C The alkyl group of 4 or the C 1 -C 4 alkoxy-substituted benzyl group, preferably R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
  • the catalyst is selected from the group consisting of 1H-tetrazole or It is preferably 1H-tetrazole.
  • the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
  • the compound of formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester), a compound of formula III Preferred is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one.
  • the present invention relates to a process for the preparation of a compound of the formula X of the compound of the formula I, which comprises reacting a compound of the formula IV with a boronating reagent in the presence of a palladium catalyst and a base to prepare the compound of the formula X,
  • X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
  • the borating agent is selected from the group consisting of pinacol borate, Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester, More preferably, it is a benzoic acid pinacol ester.
  • the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 is preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
  • the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide,
  • the intermediates and final products of each step of the preparation method of the present invention have high purity.
  • the use of dibenzylaminophosphite dibenzyl ester as the phosphorylating agent can also avoid the production of dimerization products, resulting in a higher yield of the preparation process of the present invention.
  • the preparation method of the invention has a short route, mild reaction conditions, and avoids the use of toxic, irritating and strong corrosive agents, and is environmentally friendly; Avoid the use of ultra-low temperature reaction, easy to operate and high production efficiency. Therefore, the preparation method of the present invention is particularly adapted to industrial production.
  • the concentrated product of the above step was added to a 250 ml reaction flask, and 1,4-dioxane (100 ml) and 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (8.28) were added. g, 34.5 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (0.56 g, 0.69 mmol) and aqueous cesium carbonate solution (50 ml, containing 33.72 g Barium carbonate, 103.5 mmol), heated to 70 ° C under nitrogen, reacted for 3 hours, and extracted with dichloromethane. The organic phase was separated and washed with brine, dried over anhydrous sodium sulfate, filtered, evaporated .
  • reaction solution was washed successively with saturated NaHCO 3 twice, washed once with saturated NaCl, dried over anhydrous sodium sulfate, filtered, concentrated and purified by column chromatography to give 14.89g of the title compound in a yield of 83.1%, HPLC purity by 99.62% (area Normalization method).
  • reaction solution was washed successively with saturated NaHCO 3 twice, once with saturated NaCl solution and dried over anhydrous Na 2 SO 4, filtered, concentrated in vacuo and purified by column chromatography to afford 17.11g of the title compound in a yield of 90.2%, HPLC purity detection 99.24% (area normalization method).
  • 1,4-dioxane 60 ml
  • a compound of formula XII 17.0 g, 30.89 mmol
  • a compound of formula X 6.97 g, 33.98 mmol
  • [1,1'-bis(diphenyl) were added to a 250 ml reaction flask.
  • Phosphine) ferrocene] palladium dichloride dichloromethane complex (0.51 g, 0.62 mmol)
  • aqueous sodium carbonate 30 ml, containing 10.8 g of sodium carbonate, 101.94 mmol
  • 1,4-dioxane 100 ml
  • compound of formula X 8 g, 39 mmol
  • (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyl Oxazolidin-2-one (11.3 g, 39 mmol)
  • [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (0.64 g, 0.78 mmol)
  • cesium carbonate Aqueous solution (60 ml, containing 41.93 g of cesium carbonate, 128.7 mmol), and warmed to 70 ° C under N 2 and reacted for 3 h, and extracted with dichloromethane.
  • reaction solution was washed successively with saturated NaHCO 3 solution twice, washed with a saturated NaCl solution, dried over anhydrous Na 2 SO 4, filtered, concentrated in vacuo and purified by column chromatography, to give 14.1g of the title compound in a yield of 82.8%, HPLC purity by It is 99.49% (area normalization method).
  • the concentrated product of the above step was added to a 250 ml reaction flask, and 1,4-dioxane (100 ml) and 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (8.28) were added. g, 34.5 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (0.56 g, 0.69 mmol) and aqueous cesium carbonate solution (50 ml, containing 33.72 g Barium carbonate, 103.5 mmol), heated to 70 ° C under nitrogen, reacted for 3 hours, and extracted with dichloromethane. The organic phase was separated and washed with brine, dried over anhydrous sodium sulfate, filtered, evaporated .
  • reaction solution was washed successively with saturated NaHCO 3 twice, washed once with saturated NaCl, dried over anhydrous sodium sulfate, filtered, concentrated and purified by column chromatography to give 14.89g of the title compound in a yield of 83.1%, HPLC purity by 99.62% (area Normalization method).

Abstract

Provided is a preparation method for tedizolid phosphate, an intermediate thereof of formula VII and a preparation method for the intermediates of formulae V, VII, IX and X. The preparation method has a short route, mild reaction conditions and is green and environmentally friendly. Dibenzyl diisopropylamino phosphite is used as a phosphorylation agent, avoiding the production of dimeric products and enabling a higher yield of the preparation method.

Description

一种磷酸特地唑胺、其中间体以及它们的制备方法Terbutazol phosphate, intermediate thereof and preparation method thereof 技术领域Technical field
本发明属于医药化工领域,具体而言涉及一种磷酸特地唑胺、其中间体以及它们的新的制备方法。The invention belongs to the field of medicinal chemical industry, and in particular relates to tertidazole phosphate, an intermediate thereof and a novel preparation method thereof.
背景技术Background technique
磷酸特地唑胺(tedizolidphosphate),(R)-3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)3-氟苯基)-5-羟甲基噁唑烷-2-酮二氢磷酸酯(式I),该药用于治疗革兰氏阳性菌感染,例如急性细菌性皮肤感染、MRSA引起的感染和肺部感染等。Tedizolidphosphate, (R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)3-fluorophenyl)-5-hydroxymethyl Oxazolidine-2-one dihydrogen phosphate (Formula I) for the treatment of Gram-positive bacterial infections, such as acute bacterial skin infections, MRSA-induced infections and pulmonary infections.
Figure PCTCN2015089820-appb-000001
Figure PCTCN2015089820-appb-000001
目前,公开的磷酸特地唑胺的制备方法主要有以下两种:At present, there are two main methods for preparing the disclosed tertazol phosphate:
路线1:CN1894242公开了如下制备方法:Route 1: CN1894242 discloses the following preparation method:
Figure PCTCN2015089820-appb-000002
Figure PCTCN2015089820-appb-000002
该路线第一步反应使用有毒的有机锡试剂,第二步缩合反应制备关键中间体(R)-3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)3-氟苯基)-5-羟甲基噁唑烷-2-酮的收率低至26%,第三步反应制备(R)-[3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)-3-氟苯基)-2-氧-5-唑烷基]甲基磷酸双(四丁基酯)需-78℃下进行,且反应时间长,最后一步需要使用具有刺激臭味、强腐蚀性的三氟乙酸。因此,该路线总收率低,生产成本高,反应条件苛刻,生成周期长,所用试剂有毒或刺激性、腐蚀性强,不适合工业化生产。The first step of the route uses a toxic organotin reagent, and the second step of the condensation reaction produces the key intermediate (R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridine-5- The yield of 3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one is as low as 26%, and the third step is to prepare (R)-[3-(4-(2-(2-) Methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-2-oxo-5-oxazolidine] bis(tetrabutyl ester) methyl phosphate is carried out at -78 ° C. Moreover, the reaction time is long, and the last step requires the use of trifluoroacetic acid having a pungent odor and strong corrosiveness. Therefore, the total yield of the route is low, the production cost is high, the reaction conditions are harsh, the production cycle is long, and the reagents used are toxic or irritating, corrosive, and are not suitable for industrial production.
路线2:CN102177156公开了如下合成路线:Route 2: CN102177156 discloses the following synthetic route:
该路线通过起始原料合成反应路线长,其中第二步硼化反应需在-72℃低温进行且得到的产物4-(苄氧羰基氨基)-2-氟苯硼酸的收率仅为66%并且很不纯,第四步成环反应操作步骤繁琐且反应时间长,最后一步磷酸化采用剧毒的发烟液体三氯氧磷。因此,该路线也不适应工业化大规模生产。 The route is long by the starting material synthesis reaction route, wherein the second step of the boronation reaction needs to be carried out at a low temperature of -72 ° C and the yield of the obtained product 4-(benzyloxycarbonylamino)-2-fluorobenzeneboronic acid is only 66%. And it is very impure. The fourth step of the ring-forming reaction is cumbersome and the reaction time is long. The final step of phosphorylation uses the highly toxic fuming liquid phosphorus oxychloride. Therefore, the route is not suitable for industrial mass production.
Figure PCTCN2015089820-appb-000003
Figure PCTCN2015089820-appb-000003
现有技术公开的磷酸特地唑胺的合成方法存在诸多缺陷,因此仍需制备磷酸特地唑胺的新方法。The method for synthesizing the tertidamine phosphate disclosed in the prior art has many drawbacks, and therefore a new method for preparing tertazolam phosphate is still required.
发明内容Summary of the invention
第一方面,本发明涉及磷酸特地唑胺(式I化合物)的新的制备方法。In a first aspect, the invention relates to a novel process for the preparation of terbutazol phosphate (a compound of formula I).
Figure PCTCN2015089820-appb-000004
Figure PCTCN2015089820-appb-000004
第二方面,本发明涉及式I化合物的中间体式VII化合物及其制备方法。In a second aspect, the invention relates to an intermediate compound of formula VII of a compound of formula I and a process for the preparation thereof.
Figure PCTCN2015089820-appb-000005
Figure PCTCN2015089820-appb-000005
第三方面,本发明涉及式I化合物的中间体式V化合物的制备方法。In a third aspect, the invention relates to a process for the preparation of a compound of formula V of the compound of formula I.
Figure PCTCN2015089820-appb-000006
Figure PCTCN2015089820-appb-000006
第四方面,本发明涉及式I化合物的中间体式IX化合物的制备方法。In a fourth aspect, the invention relates to a process for the preparation of a compound of formula IX of the compound of formula I.
Figure PCTCN2015089820-appb-000007
Figure PCTCN2015089820-appb-000007
第五方面,本发明涉及式I化合物的中间体式X化合物的制备方法。In a fifth aspect, the invention relates to a process for the preparation of a compound of formula X of the compound of formula I.
Figure PCTCN2015089820-appb-000008
Figure PCTCN2015089820-appb-000008
具体实施方式detailed description
式I化合物的制备方法Method for preparing compound of formula I
第一方面,本发明提供一种式I化合物的制备方法,所述方法包括:将式VII化合物进行如下脱除苄基的反应:In a first aspect, the present invention provides a process for the preparation of a compound of formula I, which comprises reacting a compound of formula VII with a benzyl group as follows:
Figure PCTCN2015089820-appb-000009
Figure PCTCN2015089820-appb-000009
进一步而言,作为所述脱除苄基反应的一种实施方式,所述脱除苄基的反应可以在催化剂和氢源存在下进行,Further, as an embodiment of the benzyl removal reaction, the benzyl removal reaction can be carried out in the presence of a catalyst and a hydrogen source.
Figure PCTCN2015089820-appb-000010
Figure PCTCN2015089820-appb-000010
其中,所述催化剂选自于Pd(OH)2/C、Pd/C、PdCl2、Pd(OAc)2、Pd(OH)2或Raney镍,优选为Pd/C。Wherein the catalyst is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
其中,所述氢源选自于H2、HCOOH、HCOONH4、NH2NH2或环己烯,优选为H2Wherein the hydrogen source is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
式I化合物的制备可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂,优选为选自于由乙酸乙酯、乙酸丁酯和C1-C8的醇所组成的组中的一种溶剂或几种溶剂的混合溶剂,最优选为选自于由乙酸乙酯、甲醇和乙醇所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述反应溶剂为甲醇。The preparation of the compound of the formula I can be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, Composition of valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO a solvent or a mixed solvent of several solvents in the group, preferably a solvent selected from the group consisting of ethyl acetate, butyl acetate and C 1 -C 8 alcohol or several solvents The mixed solvent is most preferably a solvent selected from the group consisting of ethyl acetate, methanol and ethanol or a mixed solvent of several solvents. In a specific embodiment, the reaction solvent is methanol.
作为所述脱除苄基反应的另一种实施方式,所述脱除苄基的反应可以在三氟乙酸的存在下进行, As another embodiment of the benzyl removal reaction, the benzyl removal reaction can be carried out in the presence of trifluoroacetic acid.
Figure PCTCN2015089820-appb-000011
Figure PCTCN2015089820-appb-000011
式I化合物的制备可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂选自于由二氯甲烷、三氯甲烷、四氯化碳、水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂,优选为二氯甲烷。The preparation of the compound of the formula I can be carried out by selecting a suitable reaction solvent selected from the group consisting of dichloromethane, chloroform, carbon tetrachloride, water, C 1 -C 8 alcohol, 1,4. - dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene A solvent or a mixed solvent of several solvents of a group consisting of toluene, xylene, DMF, DMAC and DMSO, preferably dichloromethane.
任选地,式I化合物的制备进一步包括将反应产物用有机溶剂纯化的步骤,所述有机溶剂包括但不限于由石油醚、乙醚、异丙醚、环己烷、二氯甲烷、三氯甲烷、四氯化碳、C1-C8的醇、1,4-二氧六环、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯和二甲苯所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述有机溶剂为乙醇。Optionally, the preparation of the compound of formula I further comprises the step of purifying the reaction product with an organic solvent including, but not limited to, petroleum ether, diethyl ether, diisopropyl ether, cyclohexane, dichloromethane, chloroform. , carbon tetrachloride, C 1 -C 8 alcohol, 1,4-dioxane, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, ethyl acetate, butyl acetate, A solvent or a mixed solvent of several solvents in a group consisting of tetrahydrofuran, acetonitrile, benzene, toluene and xylene. In a specific embodiment, the organic solvent is ethanol.
更进一步而言,作为一种具体实施方式,所述式I化合物的制备方法还包括:式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应以制备所述VII化合物,Further, as a specific embodiment, the method for preparing the compound of the formula I further comprises: reacting the compound of the formula V and the compound of the formula VI in the presence of a catalyst and an oxidizing agent to prepare the compound of the VII,
Figure PCTCN2015089820-appb-000012
Figure PCTCN2015089820-appb-000012
其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者,R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者,R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基,优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基,Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or, R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy substituted benzyl, preferably R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl,
其中,所述催化剂选自1H-四氮唑或
Figure PCTCN2015089820-appb-000013
优选为1H-四氮唑,
Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
Figure PCTCN2015089820-appb-000013
Preferred is 1H-tetrazole,
其中,所述氧化剂选自于间氯过氧苯甲酸、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢,优选为间氯过氧苯甲酸,Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
其中,反应溶剂选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二 甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂,优选为二氯甲烷,Wherein the reaction solvent is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, and a solvent or a mixed solvent of several solvents in a group consisting of ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO, preferably For methylene chloride,
其中,式VI化合物优选为二异丙氨基亚磷酸二苄酯。Among them, the compound of the formula VI is preferably dibenzyl diisopropylaminophosphite.
更进一步而言,作为一种具体实施方式,所述式I化合物的制备方法进一步还包括:按照如下步骤制备所述式V化合物:Still further, as a specific embodiment, the method for preparing the compound of formula I further comprises: preparing the compound of formula V according to the following steps:
(1)式III化合物与硼化试剂在钯催化剂和碱存在下进行反应,(1) a compound of the formula III is reacted with a borating reagent in the presence of a palladium catalyst and a base,
(2)步骤(1)的产物与式IV化合物在钯催化剂和碱存在下进行反应,(2) the product of step (1) is reacted with a compound of formula IV in the presence of a palladium catalyst and a base,
Figure PCTCN2015089820-appb-000014
Figure PCTCN2015089820-appb-000014
其中,X1和X2各自独立地选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br,
其中,所述步骤(1)的硼化试剂选自于联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000015
Figure PCTCN2015089820-appb-000016
三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000017
更优选为联硼酸频那醇酯,
Wherein the borating agent of the step (1) is selected from the group consisting of pinacol borate,
Figure PCTCN2015089820-appb-000015
Figure PCTCN2015089820-appb-000016
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000017
More preferably, it is a benzoic acid pinacol ester,
其中,所述步骤(1)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
其中,所述步骤(1)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾,Wherein said base in step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium,
其中,所述步骤(2)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst of the step (2) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
其中,所述步骤(2)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Wherein the base of the step (2) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide and lithium diisopropylamide from C 1 -C 8 . One or more of the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine Preferred is potassium acetate.
更进一步而言,作为另一种具体实施方式,所述式I化合物的制备方法进一步还包括:式X化合物与式III化合物在钯催化剂和碱存在下进行反应制备所述式V化合物, Further, as another specific embodiment, the method for preparing the compound of the formula I further comprises: preparing the compound of the formula V by reacting the compound of the formula X with a compound of the formula III in the presence of a palladium catalyst and a base,
Figure PCTCN2015089820-appb-000018
Figure PCTCN2015089820-appb-000018
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
式III化合物优选为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(式VIII),The compound of formula III is preferably (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula VIII),
Figure PCTCN2015089820-appb-000019
Figure PCTCN2015089820-appb-000019
其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
其中,所述的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸铯,Wherein the base is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide from C 1 -C 8 One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably Barium carbonate,
其中,反应溶剂为选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组中的一种溶剂或几种溶剂的混合溶剂,Wherein, the reaction solvent is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, a solvent or a mixture of several solvents in the group consisting of ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO, and NMP Solvent,
其中,式V化合物的制备在N2或Ar的保护下进行。Among them, the preparation of the compound of the formula V is carried out under the protection of N 2 or Ar.
更进一步而言,作为另一种具体实施方式,所述式I化合物的制备方法还包括:式IX化合物与式X化合物在钯催化剂和碱存在下进行反应以制备所述式VII化合物,Still further, as another specific embodiment, the method for preparing the compound of formula I further comprises: reacting a compound of formula IX with a compound of formula X in the presence of a palladium catalyst and a base to prepare the compound of formula VII,
Figure PCTCN2015089820-appb-000020
Figure PCTCN2015089820-appb-000020
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、 三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸钠或碳酸钾,最优选为碳酸钠;Wherein the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably carbonic acid Sodium or potassium carbonate, most preferably sodium carbonate;
其中,式IX化合物优选为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯)。Among them, the compound of the formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methylphosphonic acid bis(benzyl ester).
更进一步而言,作为一种具体实施方式,所述式I化合物的制备方法进一步还包括:式III化合物和式VI化合物在催化剂、氧化剂存在下进行反应以制备所述式IX化合物,Further, as a specific embodiment, the method for preparing the compound of the formula I further comprises: reacting the compound of the formula III and the compound of the formula VI in the presence of a catalyst and an oxidizing agent to prepare the compound of the formula IX,
Figure PCTCN2015089820-appb-000021
Figure PCTCN2015089820-appb-000021
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基,优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基,Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy-substituted benzyl group, preferably at the same time R 1 and R 2 is isopropyl or ethyl, most preferably R 1 and R 2 simultaneously isopropyl,
其中,所述催化剂选自于1H-四氮唑或
Figure PCTCN2015089820-appb-000022
优选为1H-四氮唑,
Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
Figure PCTCN2015089820-appb-000022
Preferred is 1H-tetrazole,
其中,所述氧化剂选自于间氯过氧苯甲酸、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢,优选为间氯过氧苯甲酸,Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
其中,式IX化合物优选为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯),式III化合物优选为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮。Wherein the compound of formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester), a compound of formula III Preferred is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one.
更进一步而言,作为一种具体实施方式,所述式I化合物的制备方法进一步还包括:式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应以制备所述式X化合物,Further, as a specific embodiment, the method for preparing the compound of the formula I further comprises: reacting the compound of the formula IV with a borating reagent in the presence of a palladium catalyst and a base to prepare the compound of the formula X,
Figure PCTCN2015089820-appb-000023
Figure PCTCN2015089820-appb-000023
其中,X2选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
其中,所述硼化试剂选自于联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000024
Figure PCTCN2015089820-appb-000025
三异丙基硼酸酯、三丙基硼酸酯、三甲 基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000026
更优选为联硼酸频那醇酯,
Wherein the borating agent is selected from the group consisting of pinacol borate,
Figure PCTCN2015089820-appb-000024
Figure PCTCN2015089820-appb-000025
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000026
More preferably, it is a benzoic acid pinacol ester,
其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Wherein the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium.
下面,将对式I化合物的制备方法的六种具体实施方式进行详细说明。In the following, six specific embodiments of the preparation method of the compound of the formula I will be described in detail.
作为第一种具体实施方式,式I化合物的制备方法包括:As a first specific embodiment, the method of preparing a compound of formula I comprises:
(1)式IX化合物与式X化合物在钯催化剂和碱存在下进行反应制备式VII化合物,(1) a compound of the formula IX is reacted with a compound of the formula X in the presence of a palladium catalyst and a base to prepare a compound of the formula VII,
(2)式VII化合物在催化剂和氢源存在下进行反应制备式I化合物,(2) a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
Figure PCTCN2015089820-appb-000027
Figure PCTCN2015089820-appb-000027
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
在一个具体实施方案中,式IX化合物为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯)(式XII),In a particular embodiment, the compound of formula IX is (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester) (Formula XII),
Figure PCTCN2015089820-appb-000028
Figure PCTCN2015089820-appb-000028
其中,所述步骤(1)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
其中,所述步骤(1)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、 叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸钠或碳酸钾,最优选为碳酸钠,Wherein the base of the step (1) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide and lithium diisopropylamide from C 1 -C 8 . One or more of the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine Kind, preferably sodium carbonate or potassium carbonate, most preferably sodium carbonate,
其中,所述步骤(1)可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂包括但不限于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述反应溶剂为1,4-二氧六环和水的混合溶剂。Wherein, the step (1) can be carried out by selecting a suitable reaction solvent according to requirements, including but not limited to water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid Butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC a solvent in a group consisting of DMSO and NMP or a mixed solvent of several solvents. In a specific embodiment, the reaction solvent is a mixed solvent of 1,4-dioxane and water.
任选地,步骤(1)的反应可以在N2或Ar的保护下进行。Optionally, the reaction of step (1) can be carried out under the protection of N 2 or Ar.
其中,所述步骤(2)的催化剂选自于Pd(OH)2/C、Pd/C、PdCl2、Pd(OAc)2、Pd(OH)2或Raney镍,优选为Pd/C。Wherein the catalyst of the step (2) is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
其中,所述步骤(2)的氢源选自于H2、HCOOH、HCOONH4、NH2NH2或环己烯,优选为H2Wherein, the hydrogen source of the step (2) is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
其中,所述步骤(2)可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂,优选为选自于由乙酸乙酯、乙酸丁酯和C1-C8的醇所组成的组中的一种溶剂或几种溶剂的混合溶剂,最优选为选自于由乙酸乙酯、甲醇和乙醇所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述反应溶剂为甲醇。Wherein, the step (2) can be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, Butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and a solvent in a group consisting of DMSO or a mixed solvent of several solvents, preferably a solvent or a group selected from the group consisting of ethyl acetate, butyl acetate, and C 1 -C 8 alcohol The mixed solvent of the solvent is most preferably a solvent selected from the group consisting of ethyl acetate, methanol and ethanol or a mixed solvent of several solvents. In a specific embodiment, the reaction solvent is methanol.
任选地,所述反应可以在N2或Ar的保护下进行。Optionally, the reaction can be carried out under the protection of N 2 or Ar.
作为上述式IX化合物的制备方法,包括:式III化合物和式VI化合物在催化剂、氧化剂存在下进行反应,As a method for preparing the compound of the above formula IX, the compound of the formula III and the compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent,
Figure PCTCN2015089820-appb-000029
Figure PCTCN2015089820-appb-000029
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
在一个具体实施方案中,式IX化合物为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯)(式XII),式III化合物为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(式XI),In a particular embodiment, the compound of formula IX is (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester) (Formula XII), the compound of formula III is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula XI),
Figure PCTCN2015089820-appb-000030
Figure PCTCN2015089820-appb-000030
其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基。优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基。Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C An alkyl group of 4 or a C 1 -C 4 alkoxy-substituted benzyl group. Preferably, R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
其中,所述催化剂选自于1H-四氮唑或
Figure PCTCN2015089820-appb-000031
优选为1H-四氮唑。
Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
Figure PCTCN2015089820-appb-000031
It is preferably 1H-tetrazole.
其中,所述氧化剂选自于间氯过氧苯甲酸(mCPBA)、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢(TBHP),优选为间氯过氧苯甲酸(mCPBA)。Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid (mCPBA). .
式IX化合物的制备可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述反应溶剂为二氯甲烷。The preparation of the compound of the formula IX can be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, Composition of valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO A solvent in a group or a mixed solvent of several solvents. In a specific embodiment, the reaction solvent is dichloromethane.
在一个具体实施方案中,式VI化合物为二异丙氨基亚磷酸二苄酯(式II),In a particular embodiment, the compound of formula VI is dibenzylaminodiphosphite (formula II),
Figure PCTCN2015089820-appb-000032
Figure PCTCN2015089820-appb-000032
作为上述式X化合物的制备方法,包括:式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应,As a method for preparing the above compound of the formula X, the method comprises: reacting a compound of the formula IV with a borating reagent in the presence of a palladium catalyst and a base,
Figure PCTCN2015089820-appb-000033
Figure PCTCN2015089820-appb-000033
其中,X2选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
在一个具体实施方案中,式IV化合物为5-溴-2-(2-甲基-2H-四唑-5-基)吡啶(式XIII)。In a particular embodiment, the compound of formula IV is 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (Formula XIII).
Figure PCTCN2015089820-appb-000034
Figure PCTCN2015089820-appb-000034
所述硼化试剂选自于联硼酸频那醇酯
Figure PCTCN2015089820-appb-000035
Figure PCTCN2015089820-appb-000036
三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000037
更优选为联硼酸频那醇酯。
The borating agent is selected from the group consisting of pinacol borate
Figure PCTCN2015089820-appb-000035
Figure PCTCN2015089820-appb-000036
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000037
More preferably, it is a benzoic acid pinacol ester.
所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。The base is selected from the C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine is preferably potassium acetate.
式X化合物的制备可以根据需要选择合适的溶剂进行反应,所述溶剂包括但不限于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述溶剂为DMSO。The preparation of the compound of the formula X can be carried out by selecting a suitable solvent, including but not limited to water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, pentane. Acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO and NMP A solvent of a group or a mixed solvent of several solvents. In a specific embodiment, the solvent is DMSO.
作为第二种具体实施方式,式I化合物的制备方法包括:As a second specific embodiment, the method for preparing a compound of formula I comprises:
i)式III化合物与硼化试剂在钯催化剂和碱存在下进行反应,i) reacting a compound of formula III with a boronating reagent in the presence of a palladium catalyst and a base,
ii)步骤i)的产物与式IV化合物在钯催化剂和碱存在下进行反应制备式V化合物,Ii) reacting the product of step i) with a compound of formula IV in the presence of a palladium catalyst and a base to prepare a compound of formula V,
iii)式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应制备式VII化合物,Iii) a compound of the formula V and a compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent to prepare a compound of the formula VII,
iv)式VII化合物在催化剂和氢源存在下进行反应制备式I化合物,Iv) a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
Figure PCTCN2015089820-appb-000038
Figure PCTCN2015089820-appb-000038
其中,X1和X2各自独立地选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
其中,R1和R2各自独立地为选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者 R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基。优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基。Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 - An alkyl group of C 4 or a C 1 -C 4 alkoxy-substituted benzyl group. Preferably, R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
所述步骤i)的硼化试剂选自于联硼酸频那醇酯
Figure PCTCN2015089820-appb-000039
Figure PCTCN2015089820-appb-000040
三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000041
Figure PCTCN2015089820-appb-000042
更优选为联硼酸频那醇酯。
The boriding agent of step i) is selected from the group consisting of pinacol borate
Figure PCTCN2015089820-appb-000039
Figure PCTCN2015089820-appb-000040
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000041
Figure PCTCN2015089820-appb-000042
More preferably, it is a benzoic acid pinacol ester.
所述步骤i)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst of the step i) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
所述步骤i)的碱选自于C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺或乙二胺中的一种或多种,优选为醋酸钾。The base of the step i) is selected from the group consisting of C 1 -C 8 sodium alkoxide, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, potassium hydroxide, One or more of sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine or ethylenediamine is preferably potassium acetate.
所述步骤ii)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst of the step ii) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
所述步骤ii)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸铯。The base of the step ii) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, potassium hydroxide from C 1 -C 8 . One or more of the group consisting of sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably cesium carbonate.
所述步骤iii)的催化剂为1H-四氮唑或
Figure PCTCN2015089820-appb-000043
优选为1H-四氮唑。
The catalyst of step iii) is 1H-tetrazole or
Figure PCTCN2015089820-appb-000043
It is preferably 1H-tetrazole.
所述步骤iii)的氧化剂选自于间氯过氧苯甲酸(mCPBA)、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢(TBHP),优选为间氯过氧苯甲酸(mCPBA)。The oxidizing agent of step iii) is selected from m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid ( mCPBA).
所述步骤iv)的催化剂选自于Pd(OH)2/C、Pd/C、PdCl2、Pd(OAc)2、Pd(OH)2或Raney镍,优选为Pd/C。The catalyst of step iv) is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
所述步骤iv)的氢源选自于H2、HCOOH、HCOONH4、NH2NH2或环己烯,优选为H2The hydrogen source of step iv) is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
作为第三种具体实施方式,式I化合物的制备方法包括:As a third specific embodiment, the preparation method of the compound of formula I includes:
i)式III化合物和式VI化合物在催化剂、氧化剂存在下进行反应制备式IX化合物, i) a compound of the formula III and a compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent to prepare a compound of the formula IX,
ii)式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应制备式X化合物,Ii) a compound of the formula IV is reacted with a boronating reagent in the presence of a palladium catalyst and a base to prepare a compound of the formula X,
iii)式IX化合物与式X化合物在钯催化剂和碱存在下进行反应制备式VII化合物,Iii) a compound of the formula IX is reacted with a compound of the formula X in the presence of a palladium catalyst and a base to prepare a compound of the formula VII,
iv)式VII化合物在催化剂和氢源存在下进行反应制备式I化合物,Iv) a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
Figure PCTCN2015089820-appb-000044
Figure PCTCN2015089820-appb-000044
其中,X1和X2各自独立地选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
其中,R1和R2各自独立地为选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基。优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基。Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 - An alkyl group of C 4 or a C 1 -C 4 alkoxy-substituted benzyl group. Preferably, R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
所述步骤i)的催化剂为1H-四氮唑或
Figure PCTCN2015089820-appb-000045
优选为1H-四氮唑。
The catalyst of step i) is 1H-tetrazole or
Figure PCTCN2015089820-appb-000045
It is preferably 1H-tetrazole.
所述步骤i)的氧化剂选自于间氯过氧苯甲酸(mCPBA)、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢(TBHP),优选为间氯过氧苯甲酸(mCPBA)。The oxidizing agent of step i) is selected from m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid ( mCPBA).
所述步骤ii)的硼化试剂选自于联硼酸频那醇酯
Figure PCTCN2015089820-appb-000046
Figure PCTCN2015089820-appb-000047
三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000048
Figure PCTCN2015089820-appb-000049
更优选为联硼酸频那醇酯。
The boriding agent of step ii) is selected from the group consisting of pinacol borate
Figure PCTCN2015089820-appb-000046
Figure PCTCN2015089820-appb-000047
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000048
Figure PCTCN2015089820-appb-000049
More preferably, it is a benzoic acid pinacol ester.
所述步骤ii)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、 Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst of the step ii) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
所述步骤ii)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Said step ii) is a base selected from the C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, hydroxide One or more selected from the group consisting of sodium, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably It is potassium acetate.
所述步骤iii)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst of the step iii) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
所述步骤iii)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸钠或碳酸钾,最优选为碳酸钠。Said step iii) is a base selected from the C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, hydroxide One or more selected from the group consisting of sodium, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably Most preferred is sodium carbonate or potassium carbonate.
所述步骤iv)的催化剂选自于Pd(OH)2/C、Pd/C、PdCl2、Pd(OAc)2、Pd(OH)2或Raney镍,优选为Pd/C。The catalyst of step iv) is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
所述步骤iv)的氢源选自于H2、HCOOH、HCOONH4、NH2NH2或环己烯,优选为H2The hydrogen source of step iv) is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
作为第四种具体实施方式,式I化合物的制备方法包括:As a fourth specific embodiment, the method for preparing a compound of formula I comprises:
(1)式X化合物与式III化合物在钯催化剂和碱存在下进行反应制备式V化合物,(1) a compound of the formula X is reacted with a compound of the formula III in the presence of a palladium catalyst and a base to prepare a compound of the formula V,
(2)式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应制备式VII化合物,(2) a compound of the formula V and a compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent to prepare a compound of the formula VII,
(3)式VII化合物在催化剂和氢源存在下进行反应制备式I化合物,(3) a compound of the formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of the formula I,
Figure PCTCN2015089820-appb-000050
Figure PCTCN2015089820-appb-000050
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
在一个具体实施方案中,式III化合物为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(式VIII), In a particular embodiment, the compound of formula III is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula VIII),
Figure PCTCN2015089820-appb-000051
Figure PCTCN2015089820-appb-000051
其中R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基。优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基。Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or tert-butyl; or R 1 and R 2 are each independently selected a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C 4 Alkyl or C 1 -C 4 alkoxy-substituted benzyl. Preferably, R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
其中,所述步骤(1)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。Wherein the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex.
其中所述步骤(1)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸铯。Wherein said base in step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, One or more of the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine It is preferably cesium carbonate.
所述步骤(1)可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂包括但不限于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,步骤(1)的反应溶剂为DMSO。The step (1) may be carried out by selecting a suitable reaction solvent according to requirements, including but not limited to water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyl Acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO A solvent or a mixed solvent of several solvents in a group consisting of NMP. In a specific embodiment, the reaction solvent of step (1) is DMSO.
任选地,步骤(1)反应可以在N2或Ar的保护下进行。Optionally, the step (1) reaction can be carried out under the protection of N 2 or Ar.
其中,所述步骤(2)的催化剂选自于1H-四氮唑或
Figure PCTCN2015089820-appb-000052
优选为1H-四氮唑。
Wherein the catalyst of the step (2) is selected from 1H-tetrazole or
Figure PCTCN2015089820-appb-000052
It is preferably 1H-tetrazole.
其中,所述步骤(2)的氧化剂选自于间氯过氧苯甲酸(mCPBA)、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢(TBHP),优选为间氯过氧苯甲酸(mCPBA)。Wherein the oxidizing agent of the step (2) is selected from m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxy Benzoic acid (mCPBA).
所述步骤(2)可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述反应溶剂为二氯甲烷。The step (2) may be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid. , valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO A solvent or a mixed solvent of several solvents in the composition group. In a specific embodiment, the reaction solvent is dichloromethane.
在一个具体实施方案中,式VI化合物为二异丙氨基亚磷酸二苄酯(式II), In a particular embodiment, the compound of formula VI is dibenzylaminodiphosphite (formula II),
Figure PCTCN2015089820-appb-000053
Figure PCTCN2015089820-appb-000053
其中,所述步骤(3)的催化剂选自于Pd(OH)2/C、Pd/C、PdCl2、Pd(OAc)2、Pd(OH)2或Raney镍,优选为Pd/C。Wherein the catalyst of the step (3) is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
其中,所述步骤(3)的氢源选自于H2、HCOOH、HCOONH4、NH2NH2或环己烯,优选为H2Wherein, the hydrogen source of the step (3) is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
所述步骤(3)可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂,优选为选自于由乙酸乙酯、乙酸丁酯和C1-C8的醇所组成的组中的一种溶剂或几种溶剂的混合溶剂,最优选为选自于由乙酸乙酯、甲醇和乙醇所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述溶剂为甲醇。The step (3) may be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid. , valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO One solvent or a mixed solvent of several solvents in the group consisting of one solvent or several solvents selected from the group consisting of ethyl acetate, butyl acetate and C 1 -C 8 alcohols. The mixed solvent is most preferably a solvent selected from the group consisting of ethyl acetate, methanol and ethanol or a mixed solvent of several solvents. In a specific embodiment, the solvent is methanol.
作为第五种具体实施方式,式I化合物的制备方法包括:As a fifth specific embodiment, the method for preparing a compound of formula I comprises:
i)式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应制备式X化合物,i) a compound of the formula IV is reacted with a boronating reagent in the presence of a palladium catalyst and a base to prepare a compound of the formula X,
ii)式X化合物与式III化合物在钯催化剂和碱存在下进行反应制备式V化合物,Ii) a compound of the formula X is reacted with a compound of the formula III in the presence of a palladium catalyst and a base to prepare a compound of the formula V,
iii)式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应制备式VII化合物,Iii) a compound of the formula V and a compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent to prepare a compound of the formula VII,
iv)式VII化合物在催化剂和氢源存在下进行反应制备式I化合物,Iv) a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
Figure PCTCN2015089820-appb-000054
Figure PCTCN2015089820-appb-000054
其中,X1和X2各自独立地选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
其中,R1和R2各自独立地为选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基。优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基。 Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 - An alkyl group of C 4 or a C 1 -C 4 alkoxy-substituted benzyl group. Preferably, R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
所述步骤i)的硼化试剂选自于联硼酸频那醇酯
Figure PCTCN2015089820-appb-000055
Figure PCTCN2015089820-appb-000056
三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000057
Figure PCTCN2015089820-appb-000058
更优选为联硼酸频那醇酯。
The boriding agent of step i) is selected from the group consisting of pinacol borate
Figure PCTCN2015089820-appb-000055
Figure PCTCN2015089820-appb-000056
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000057
Figure PCTCN2015089820-appb-000058
More preferably, it is a benzoic acid pinacol ester.
所述步骤i)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst of the step i) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
所述步骤i)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Said step i) a base selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, hydroxide One or more selected from the group consisting of sodium, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably It is potassium acetate.
所述步骤ii)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst of the step ii) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
所述步骤ii)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸铯。Said step ii) is a base selected from the C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, hydroxide One or more selected from the group consisting of sodium, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably It is barium carbonate.
所述步骤iii)的催化剂为1H-四氮唑或
Figure PCTCN2015089820-appb-000059
优选为1H-四氮唑。
The catalyst of step iii) is 1H-tetrazole or
Figure PCTCN2015089820-appb-000059
It is preferably 1H-tetrazole.
所述步骤iii)的氧化剂选自于间氯过氧苯甲酸(mCPBA)、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢(TBHP),优选为间氯过氧苯甲酸(mCPBA)。The oxidizing agent of step iii) is selected from m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid ( mCPBA).
所述步骤iv)的催化剂选自于Pd(OH)2/C、Pd/C、PdCl2、Pd(OAc)2、Pd(OH)2或Raney镍,优选为Pd/C。The catalyst of step iv) is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C.
所述步骤iv)的氢源选自于H2、HCOOH、HCOONH4、NH2NH2或环己烯,优选为H2The hydrogen source of step iv) is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 .
作为第六种具体实施方式,式I化合物的制备方法包括:As a sixth specific embodiment, the method for preparing a compound of formula I comprises:
i)式III化合物与硼化试剂在钯催化剂和碱存在下进行反应,i) reacting a compound of formula III with a boronating reagent in the presence of a palladium catalyst and a base,
ii)步骤i)的产物与式IV化合物在钯催化剂和碱存在下进行反应制备式V化合物,Ii) reacting the product of step i) with a compound of formula IV in the presence of a palladium catalyst and a base to prepare a compound of formula V,
iii)式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应制备式VII化合物, Iii) a compound of the formula V and a compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent to prepare a compound of the formula VII,
iv)式VII化合物在三氟乙酸存在下进行反应制备式I化合物,Iv) a compound of formula VII is reacted in the presence of trifluoroacetic acid to prepare a compound of formula I,
Figure PCTCN2015089820-appb-000060
Figure PCTCN2015089820-appb-000060
其中,X1和X2各自独立地选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
其中,R1和R2各自独立地为选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基。优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基。Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 - An alkyl group of C 4 or a C 1 -C 4 alkoxy-substituted benzyl group. Preferably, R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
所述步骤i)的硼化试剂选自于联硼酸频那醇酯
Figure PCTCN2015089820-appb-000061
Figure PCTCN2015089820-appb-000062
三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000063
Figure PCTCN2015089820-appb-000064
更优选为联硼酸频那醇酯。
The boriding agent of step i) is selected from the group consisting of pinacol borate
Figure PCTCN2015089820-appb-000061
Figure PCTCN2015089820-appb-000062
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000063
Figure PCTCN2015089820-appb-000064
More preferably, it is a benzoic acid pinacol ester.
所述步骤i)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst of the step i) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
所述步骤i)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。The base of the step i) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, potassium hydroxide from C 1 -C 8 . One or more of the group consisting of sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably potassium acetate.
所述步骤ii)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。 The palladium catalyst of the step ii) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex .
所述步骤ii)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸铯。The base of the step ii) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, potassium hydroxide from C 1 -C 8 . One or more of the group consisting of sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably cesium carbonate.
所述步骤iii)的催化剂为1H-四氮唑或
Figure PCTCN2015089820-appb-000065
优选为1H-四氮唑。
The catalyst of step iii) is 1H-tetrazole or
Figure PCTCN2015089820-appb-000065
It is preferably 1H-tetrazole.
所述步骤iii)的氧化剂选自于间氯过氧苯甲酸(mCPBA)、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢(TBHP),优选为间氯过氧苯甲酸(mCPBA)。The oxidizing agent of step iii) is selected from m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid ( mCPBA).
本实施方式中的所述式VI化合物可以通过市售获得,也可以通过现有技术的方法制备得到,例如通过如下方法制备,The compound of the formula VI in the present embodiment can be obtained commercially, or can be produced by a method of the prior art, for example, by the following method.
Figure PCTCN2015089820-appb-000066
Figure PCTCN2015089820-appb-000066
举例而言,式II化合物可以通过市售获得,也可以通过如下方法制备,For example, the compound of formula II can be obtained commercially, or can be prepared by the following method.
Figure PCTCN2015089820-appb-000067
Figure PCTCN2015089820-appb-000067
应当理解,本发明的式II化合物、式VI化合物、式IX化合物、式VII化合物或式XII化合物亦涵盖苄基上的苯环被单取代或多取代的化合物,只要上述反应能够进行即可,所述取代基包括但不限于卤素、羟基、氨基、氰基、羧基、磺酰基、巯基、三氟甲基、硝基、苯基、苄基、苄氧基、吡啶基、哌啶基、羟甲基、羟乙基、羟丙基、任选被卤素或C1-C6烷氧基取代的C1-C6烷基、任选被卤素或C1-C6烷氧基取代的C1-C6烷氧基、C1-C6烷硫基、C1-C6烷氧基羰基、C1-C6烷基羰基、C1-C6烷基氨基、C1-C6烷基羰基氧基、C3-C7环烷基、C3-C7环烷氧基或C3-C7环烷基甲氧基。It should be understood that the compound of the formula II, the compound of the formula VI, the compound of the formula IX, the compound of the formula VII or the compound of the formula XII of the present invention also encompasses a compound in which the benzene ring on the benzyl group is mono- or polysubstituted, as long as the above reaction can be carried out. Substituents include, but are not limited to, halogen, hydroxy, amino, cyano, carboxy, sulfonyl, decyl, trifluoromethyl, nitro, phenyl, benzyl, benzyloxy, pyridyl, piperidinyl, hydroxymethyl group, hydroxyethyl, hydroxypropyl, optionally substituted with halogen or C 1 -C 6 alkoxy-substituted C 1 -C 6 alkyl, optionally substituted by halogen or C 1 -C 6 alkoxy group, a C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkoxycarbonyl, C 1 -C 6 alkylcarbonyl, C 1 -C 6 alkylamino, C 1 -C 6 alkane Alkylcarbonyloxy, C 3 -C 7 cycloalkyl, C 3 -C 7 cycloalkoxy or C 3 -C 7 cycloalkylmethoxy.
应当理解,本发明的钯催化剂还可以是各种钯催化剂与配体制备的各种钯配合物化合物,所述配体包括但不限于PCy3、AsPh3、n-Bu3P、(MeO)3P、Ph2P(CH2)2PPh2(dppe)或Ph2P(CH2)3PPh2(dppp)。It should be understood that the palladium catalyst of the present invention may also be various palladium complex compounds prepared from various palladium catalysts and ligands including, but not limited to, PCy 3 , AsPh 3 , n-Bu 3 P, (MeO) 3 P, Ph 2 P(CH 2 ) 2 PPh 2 (dppe) or Ph 2 P(CH 2 ) 3 PPh 2 (dppp).
本文所用C1-Cn包括C1-C2、C1-C3、……C1-Cn。举例而言,“C1-C8”是指该部分中具有1-8个碳原子,即包含1个碳原子、2个碳原子、3个碳原子、4个碳原子、5个碳原子,6个碳原子、7个碳原子或8个碳原子,C1-C2和C3-C7也一样。因此,举例而言,“C1-C8的醇钠”是指有1-8个碳原子的 醇钠,即所述醇钠包含1个碳原子、2个碳原子、3个碳原子、4个碳原子、5个碳原子,6个碳原子、7个碳原子或8个碳原子;再如“C1-C6烷基”是指有1-6个碳原子的烷基,即所述烷基包含1个碳原子、2个碳原子、3个碳原子、4个碳原子、5个碳原子或6个碳原子,更具体的,例如“C1-C4的烷基”是指有1-4个碳原子烷基,即所述烷基选自甲基、乙基、丙基、异丙基、正丁基、异丁基、仲丁基和叔丁基。C 1 -C n as used herein includes C 1 -C 2 , C 1 -C 3 , ... C 1 -C n . For example, "C 1 -C 8 " means that the moiety has 1-8 carbon atoms, that is, contains 1 carbon atom, 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms. , 6 carbon atoms, 7 carbon atoms or 8 carbon atoms, and C 1 -C 2 and C 3 -C 7 are also the same. Thus, for example, "a sodium alkoxide of C 1 -C 8 " means a sodium alkoxide having from 1 to 8 carbon atoms, that is, the sodium alkoxide contains one carbon atom, two carbon atoms, three carbon atoms, 4 carbon atoms, 5 carbon atoms, 6 carbon atoms, 7 carbon atoms or 8 carbon atoms; and, for example, "C 1 -C 6 alkyl" means an alkyl group having 1 to 6 carbon atoms, that is, The alkyl group contains 1 carbon atom, 2 carbon atoms, 3 carbon atoms, 4 carbon atoms, 5 carbon atoms or 6 carbon atoms, more specifically, for example, "C 1 -C 4 alkyl group" It means an alkyl group having 1 to 4 carbon atoms, that is, the alkyl group is selected from the group consisting of methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl and tert-butyl.
本发明所述的“dppf”为1,1′-双(二苯基膦)二茂铁。The "dppf" described in the present invention is 1,1'-bis(diphenylphosphino)ferrocene.
本发明所述的“dba”为二亚苄基丙酮。The "dba" described in the present invention is dibenzylideneacetone.
本发明所述的“PCy3”为三环己基膦。The "PCy 3 " described in the present invention is tricyclohexylphosphine.
本发明所述的“dppe”为1,2-双(二苯基膦)乙烷。The "dppe" described in the present invention is 1,2-bis(diphenylphosphino)ethane.
本发明所述的“dppp”为1,3-双(二苯基膦)丙烷。The "dppp" described in the present invention is 1,3-bis(diphenylphosphino)propane.
中间体式VII化合物及其制备方法Intermediate formula VII compound and preparation method thereof
第二方面,本发明提供了式VII化合物,In a second aspect, the present invention provides a compound of formula VII,
Figure PCTCN2015089820-appb-000068
Figure PCTCN2015089820-appb-000068
本发明还提供一种式VII化合物的制备方法。The invention also provides a process for the preparation of a compound of formula VII.
下面,就VII化合物的制备方法的两种具体实施方式记载如下:Hereinafter, two specific embodiments of the preparation method of the VII compound are described as follows:
作为式VII化合物制备方法的第一种具体实施方式,所述方法包括:式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应,As a first embodiment of the method for preparing a compound of formula VII, the method comprises: reacting a compound of formula V with a compound of formula VI in the presence of a catalyst, an oxidizing agent,
Figure PCTCN2015089820-appb-000069
Figure PCTCN2015089820-appb-000069
其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基。优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基。Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C An alkyl group of 4 or a C 1 -C 4 alkoxy-substituted benzyl group. Preferably, R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
其中,所述催化剂选自1H-四氮唑或
Figure PCTCN2015089820-appb-000070
优选为1H-四氮唑。
Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
Figure PCTCN2015089820-appb-000070
It is preferably 1H-tetrazole.
其中,所述氧化剂选自于间氯过氧苯甲酸(mCPBA)、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢(TBHP),优选为间氯过氧苯甲酸(mCPBA)。Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid (mCPBA). .
式VII化合物的制备可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂选自水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述反应溶剂为二氯甲烷。The preparation of the compound of the formula VII can be carried out by selecting a suitable reaction solvent selected from the group consisting of water, a C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid. a group consisting of acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO A solvent or a mixed solvent of several solvents. In a specific embodiment, the reaction solvent is dichloromethane.
在一个具体实施方案中,式VI化合物为二异丙氨基亚磷酸二苄酯(式II),In a particular embodiment, the compound of formula VI is dibenzylaminodiphosphite (formula II),
Figure PCTCN2015089820-appb-000071
Figure PCTCN2015089820-appb-000071
对于上述式V化合物,可以通过如下两种制备方法的任意一种进行制备。The compound of the above formula V can be produced by any one of the following two production methods.
作为式V化合物的制备方法的第一种具体实施方式,所述方法包括:As a first specific embodiment of the preparation method of the compound of formula V, the method comprises:
(1)式III化合物与硼化试剂在钯催化剂和碱存在下进行反应,(1) a compound of the formula III is reacted with a borating reagent in the presence of a palladium catalyst and a base,
(2)步骤(1)的产物与式IV化合物在钯催化剂和碱存在下进行反应,(2) the product of step (1) is reacted with a compound of formula IV in the presence of a palladium catalyst and a base,
Figure PCTCN2015089820-appb-000072
Figure PCTCN2015089820-appb-000072
其中,X1和X2各自独立地选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
在一个具体实施方案中,式III化合物为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮。In a particular embodiment, the compound of formula III is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one.
在一个具体实施方案中,式IV化合物为5-溴-2-(2-甲基-2H-四唑-5-基)吡啶。In a particular embodiment, the compound of formula IV is 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine.
所述步骤(1)的硼化试剂选自于联硼酸频那醇酯
Figure PCTCN2015089820-appb-000073
Figure PCTCN2015089820-appb-000074
三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000075
Figure PCTCN2015089820-appb-000076
更优选为联硼酸频那醇酯。
The borating agent of the step (1) is selected from the group consisting of pinacol borate
Figure PCTCN2015089820-appb-000073
Figure PCTCN2015089820-appb-000074
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000075
Figure PCTCN2015089820-appb-000076
More preferably, it is a benzoic acid pinacol ester.
所述步骤(1)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex Things.
所述步骤(2)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst of the step (2) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex Things.
所述步骤(1)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。The base of the step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, and hydroxide. One or more of the group consisting of potassium, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine is preferably potassium acetate.
所述步骤(2)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸铯。Said base of step (2) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, One or more of the group consisting of potassium, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine is preferably cesium carbonate.
式V化合物的制备可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂包括但不限于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,步骤(1)的溶剂为DMSO,步骤(2)的溶剂为1,4-二氧六环和水的混合溶剂。The preparation of the compound of the formula V can be carried out by selecting a suitable reaction solvent including, but not limited to, water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid. , valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO and A solvent of a group consisting of NMP or a mixed solvent of several solvents. In a specific embodiment, the solvent of step (1) is DMSO, and the solvent of step (2) is a mixed solvent of 1,4-dioxane and water.
任选地,步骤(1)和步骤(2)的反应可以在N2或氩气的保护下进行。Optionally, the reaction of step (1) and step (2) can be carried out under the protection of N 2 or argon.
作为上述式V化合物的制备方法的第二种具体实施方式,所述方法包括:式X化合物与式III化合物在钯催化剂和碱存在下进行反应制备式V化合物,As a second specific embodiment of the preparation method of the above compound of the formula V, the method comprises: reacting a compound of the formula X with a compound of the formula III in the presence of a palladium catalyst and a base to prepare a compound of the formula V,
Figure PCTCN2015089820-appb-000077
Figure PCTCN2015089820-appb-000077
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
在一个具体实施方案中,式III化合物为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(式VIII),In a particular embodiment, the compound of formula III is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula VIII),
Figure PCTCN2015089820-appb-000078
Figure PCTCN2015089820-appb-000078
其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 is preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂(LDA)、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳 酸氢钾、三乙胺、二乙胺或乙二胺所组成的组中的一种或多种,优选为碳酸铯。Wherein the base is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide (LDA), hydrogen from C 1 -C 8 . One or more of the group consisting of sodium oxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine or ethylenediamine, Preference is given to cesium carbonate.
式V化合物的制备可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂包括但不限于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,步骤(1)的溶剂为DMSO,步骤(2)的溶剂为1,4-二氧六环和水的混合溶剂。The preparation of the compound of the formula V can be carried out by selecting a suitable reaction solvent including, but not limited to, water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid. , valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO and A solvent in a group consisting of NMP or a mixed solvent of several solvents. In a specific embodiment, the solvent of step (1) is DMSO, and the solvent of step (2) is a mixed solvent of 1,4-dioxane and water.
任选地,式V化合物的制备可以在N2或Ar的保护下进行。Optionally, the preparation of the compound of formula V can be carried out under the protection of N 2 or Ar.
作为式VII化合物制备方法的第二种具体实施方式,所述方法包括:式IX化合物与式X化合物在钯催化剂和碱存在下进行反应制备式VII化合物,A second embodiment of the process for the preparation of a compound of formula VII, which comprises reacting a compound of formula IX with a compound of formula X in the presence of a palladium catalyst and a base to prepare a compound of formula VII,
Figure PCTCN2015089820-appb-000079
Figure PCTCN2015089820-appb-000079
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
在一个具体实施方案中,式IX化合物为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯)(式XII),In a particular embodiment, the compound of formula IX is (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester) (Formula XII),
Figure PCTCN2015089820-appb-000080
Figure PCTCN2015089820-appb-000080
其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 is preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸钠或碳酸钾,最优选为碳酸钠。Wherein the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably carbonic acid Sodium or potassium carbonate, most preferably sodium carbonate.
其中,式VII化合物的制备可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂包括但不限于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述反应溶剂为1,4-二氧六环和水的混合溶剂。Wherein, the preparation of the compound of the formula VII can be carried out by selecting a suitable reaction solvent including, but not limited to, water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, and the like. Butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, A solvent or a mixed solvent of several solvents in a group consisting of DMSO and NMP. In a specific embodiment, the reaction solvent is a mixed solvent of 1,4-dioxane and water.
任选地,式VII化合物的制备可以在N2或Ar的保护下进行。 Optionally, the preparation of the compound of formula VII can be carried out under the protection of N 2 or Ar.
作为上述式IX化合物的制备方法,包括:式III化合物和式VI化合物在催化剂、氧化剂存在下进行反应,As a method for preparing the compound of the above formula IX, the compound of the formula III and the compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent,
Figure PCTCN2015089820-appb-000081
Figure PCTCN2015089820-appb-000081
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
在一个具体实施方案中,式IX化合物为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯)(式XII),式III化合物为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(式XI),In a particular embodiment, the compound of formula IX is (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester) (Formula XII), the compound of formula III is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula XI),
Figure PCTCN2015089820-appb-000082
Figure PCTCN2015089820-appb-000082
其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基。优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基。Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C An alkyl group of 4 or a C 1 -C 4 alkoxy-substituted benzyl group. Preferably, R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
其中,所述催化剂选自1H-四氮唑或
Figure PCTCN2015089820-appb-000083
优选为1H-四氮唑。
Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
Figure PCTCN2015089820-appb-000083
It is preferably 1H-tetrazole.
其中,所述氧化剂选自于间氯过氧苯甲酸(mCPBA)、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢(TBHP),优选为间氯过氧苯甲酸(mCPBA)。Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, peroxyacetic acid, peroxybenzoic acid or t-butyl hydroperoxide (TBHP), preferably m-chloroperoxybenzoic acid (mCPBA). .
式IX化合物的制备可以根据需要选择合适的反应溶剂进行反应,所述反应溶剂选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述反应溶剂为二氯甲烷。The preparation of the compound of the formula IX can be carried out by selecting a suitable reaction solvent selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, Composition of valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO A solvent in a group or a mixed solvent of several solvents. In a specific embodiment, the reaction solvent is dichloromethane.
在一个具体实施方案中,式VI化合物为二异丙氨基亚磷酸二苄酯(式II), In a particular embodiment, the compound of formula VI is dibenzylaminodiphosphite (formula II),
Figure PCTCN2015089820-appb-000084
Figure PCTCN2015089820-appb-000084
作为上述式X化合物的制备方法,可以包括:式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应,As a method for preparing the above compound of the formula X, it may include: reacting the compound of the formula IV with a borating reagent in the presence of a palladium catalyst and a base,
Figure PCTCN2015089820-appb-000085
Figure PCTCN2015089820-appb-000085
其中,X2选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
在一个具体实施方案中,式IV化合物为5-溴-2-(2-甲基-2H-四唑-5-基)吡啶(式XIII)。In a particular embodiment, the compound of formula IV is 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (Formula XIII).
Figure PCTCN2015089820-appb-000086
Figure PCTCN2015089820-appb-000086
所述硼化试剂选自于联硼酸频那醇酯
Figure PCTCN2015089820-appb-000087
Figure PCTCN2015089820-appb-000088
三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000089
更优选为联硼酸频那醇酯。
The borating agent is selected from the group consisting of pinacol borate
Figure PCTCN2015089820-appb-000087
Figure PCTCN2015089820-appb-000088
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000089
More preferably, it is a benzoic acid pinacol ester.
所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。The palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。The base is selected from the C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine is preferably potassium acetate.
式X化合物的制备可以根据需要选择合适的溶剂进行反应,所述反应溶剂包括但不限于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP 所组成的组的一种溶剂或几种溶剂的混合溶剂。在一个具体实施方案中,所述反应溶剂为DMSO。The preparation of the compound of the formula X can be carried out by selecting a suitable solvent including, but not limited to, water, a C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, and the like. Valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO and NMP A solvent of the group consisting of or a mixed solvent of several solvents. In a specific embodiment, the reaction solvent is DMSO.
中间体式V化合物的制备方法Method for preparing intermediate formula V compound
第三方面,本发明涉及式I化合物的中间体式V化合物的制备方法。In a third aspect, the invention relates to a process for the preparation of a compound of formula V of the compound of formula I.
作为一种具体实施方式,中间体式V化合物的制备方法包括:按照如下步骤制备所述式V化合物:As a specific embodiment, the preparation method of the intermediate compound of formula V comprises: preparing the compound of formula V according to the following steps:
(1)式III化合物与硼化试剂在钯催化剂和碱存在下进行反应,(1) a compound of the formula III is reacted with a borating reagent in the presence of a palladium catalyst and a base,
(2)步骤(1)的产物与式IV化合物在钯催化剂和碱存在下进行反应,(2) the product of step (1) is reacted with a compound of formula IV in the presence of a palladium catalyst and a base,
Figure PCTCN2015089820-appb-000090
Figure PCTCN2015089820-appb-000090
其中,X1和X2各自独立地选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br.
其中,所述步骤(1)的硼化试剂选自于联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000091
Figure PCTCN2015089820-appb-000092
三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000093
更优选为联硼酸频那醇酯。
Wherein the borating agent of the step (1) is selected from the group consisting of pinacol borate,
Figure PCTCN2015089820-appb-000091
Figure PCTCN2015089820-appb-000092
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000093
More preferably, it is a benzoic acid pinacol ester.
其中,所述步骤(1)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。Wherein the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex.
其中,所述步骤(1)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Wherein said base in step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium.
其中,所述步骤(2)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。Wherein the palladium catalyst of the step (2) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex.
其中,所述步骤(2)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Wherein the base of the step (2) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide and lithium diisopropylamide from C 1 -C 8 . One or more of the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine Preferred is potassium acetate.
作为另一种具体实施方式,中间体式V化合物的制备方法包括:式X化合物与式III化合物在钯催化剂和碱存在下进行反应制备所述式V化合物, As another specific embodiment, the preparation method of the intermediate formula V compound comprises: preparing the compound of the formula V by reacting the compound of the formula X with the compound of the formula III in the presence of a palladium catalyst and a base,
Figure PCTCN2015089820-appb-000094
Figure PCTCN2015089820-appb-000094
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
式III化合物优选为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(式VIII),The compound of formula III is preferably (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula VIII),
Figure PCTCN2015089820-appb-000095
Figure PCTCN2015089820-appb-000095
其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 is preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
其中,所述的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸铯。Wherein the base is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide from C 1 -C 8 One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably Barium carbonate.
其中,所述反应的溶剂为选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组中的一种溶剂或几种溶剂的混合溶剂;Wherein, the solvent for the reaction is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, and ring. a solvent or a group of a group consisting of pentanone, hexanone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO, and NMP a solvent mixture;
其中,式V化合物的制备在N2或Ar的保护下进行。Among them, the preparation of the compound of the formula V is carried out under the protection of N 2 or Ar.
中间体式IX化合物的制备方法Method for preparing intermediate formula IX compound
第四方面,本发明涉及式I化合物的中间体式IX化合物的制备方法,所述方法包括:式III化合物和式VI化合物在催化剂、氧化剂存在下进行反应以制备所述式IX化合物,In a fourth aspect, the present invention relates to a process for the preparation of a compound of the formula IX of the compound of the formula I, which comprises reacting a compound of the formula III and a compound of the formula VI in the presence of a catalyst and an oxidizing agent to prepare the compound of the formula IX,
Figure PCTCN2015089820-appb-000096
Figure PCTCN2015089820-appb-000096
其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基,优选R1和R2同时为 异丙基或乙基,最优选R1和R2同时为异丙基。Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C The alkyl group of 4 or the C 1 -C 4 alkoxy-substituted benzyl group, preferably R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl.
其中,所述催化剂选自于1H-四氮唑或
Figure PCTCN2015089820-appb-000097
优选为1H-四氮唑。
Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
Figure PCTCN2015089820-appb-000097
It is preferably 1H-tetrazole.
其中,所述氧化剂选自于间氯过氧苯甲酸、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢,优选为间氯过氧苯甲酸。Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
其中,式IX化合物优选为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯),式III化合物优选为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮。Wherein the compound of formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester), a compound of formula III Preferred is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one.
中间体式X化合物的制备方法Method for preparing intermediate formula X compound
第五方面,本发明涉及式I化合物的中间体式X化合物的制备方法,所述方法包括:式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应以制备所述式X化合物,In a fifth aspect, the present invention relates to a process for the preparation of a compound of the formula X of the compound of the formula I, which comprises reacting a compound of the formula IV with a boronating reagent in the presence of a palladium catalyst and a base to prepare the compound of the formula X,
Figure PCTCN2015089820-appb-000098
Figure PCTCN2015089820-appb-000098
其中,X2选自F、Cl、Br或I,优选为Br或I,最优选为Br。Wherein X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br.
其中,所述硼化试剂选自于联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000099
Figure PCTCN2015089820-appb-000100
三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
Figure PCTCN2015089820-appb-000101
更优选为联硼酸频那醇酯。
Wherein the borating agent is selected from the group consisting of pinacol borate,
Figure PCTCN2015089820-appb-000099
Figure PCTCN2015089820-appb-000100
Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
Figure PCTCN2015089820-appb-000101
More preferably, it is a benzoic acid pinacol ester.
其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物。Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 is preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex.
其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Wherein the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium.
本发明的制备方法每一步的中间体和最终产品均具有高纯度。另外,采用二异丙胺基亚磷酸二苄酯作为磷酰化试剂,还可避免产生二聚化产物,使得本发明的制备方法具有更高收率。本发明的制备方法路线较短,反应条件温和,还避免使用有毒、有刺激性和强腐蚀性试剂,绿色环保;同时 避免使用超低温反应,操作简便易制备,生产效率高。因此,本发明的制备方法特别适应工业化生产。The intermediates and final products of each step of the preparation method of the present invention have high purity. In addition, the use of dibenzylaminophosphite dibenzyl ester as the phosphorylating agent can also avoid the production of dimerization products, resulting in a higher yield of the preparation process of the present invention. The preparation method of the invention has a short route, mild reaction conditions, and avoids the use of toxic, irritating and strong corrosive agents, and is environmentally friendly; Avoid the use of ultra-low temperature reaction, easy to operate and high production efficiency. Therefore, the preparation method of the present invention is particularly adapted to industrial production.
实施例Example
本发明通过以下实施例,它们仅仅是实施例,并不限制本发明,凡是基于本发明所实现的技术,均属于本发明的范围。The invention is exemplified by the following examples, which are merely examples and are not intended to limit the invention, and all of the techniques based on the invention are within the scope of the invention.
实施例1磷酸特地唑胺(式I化合物)的制备Example 1 Preparation of tertazolidin phosphate (compound of formula I)
步骤1 (R)-3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)3-氟苯基)-5-羟甲基噁唑烷-2-酮(式V化合物)的制备Step 1 (R)-3-(4-(2-(2-Methyltetrazol-5-yl)pyridin-5-yl)3-fluorophenyl)-5-hydroxymethyloxazolidine-2- Preparation of ketones (compounds of formula V)
250ml反应瓶中加入DMSO(100ml),(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(10g,34.5mmol)、联硼酸频那醇酯(17.52g,69mmol)、[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物(1.41g,1.73mmol)和醋酸钾(13.5g,138mmol),氮气保护下,升温至80℃,反应14小时。停止加热,降至室温,水/乙酸乙酯萃取3次,合并有机层,有机层用饱和食盐水洗涤3次,无水硫酸钠干燥,抽滤浓缩。DMSO (100 ml), (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (10 g, 34.5 mmol), boronic acid frequency was added to a 250 ml reaction flask. Alcohol ester (17.52 g, 69 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (1.41 g, 1.73 mmol) and potassium acetate (13.5 g) , 138 mmol), heated to 80 ° C under nitrogen, and reacted for 14 hours. The heating was stopped, the temperature was lowered to room temperature, and the mixture was combined with water and ethyl acetate. The organic layer was combined and evaporated.
将上述步骤的浓缩产物加入到250ml反应瓶中,加入1,4-二氧六环(100ml)、5-溴-2-(2-甲基-2H-四唑-5-基)吡啶(8.28g,34.5mmol)、[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物(0.56g,0.69mmol)和碳酸铯水溶液(50ml,含33.72g碳酸铯,103.5mmol),氮气保护下,升温至70℃,反应3小时,加入二氯甲烷萃取。分离所得的有机相用饱和食盐水洗涤、无水硫酸钠脱水、过滤、真空浓缩并通过柱色谱纯化,得到10.6g固体,收率83.0%,HPLC检测纯度为98.34%(面积归一化法)。The concentrated product of the above step was added to a 250 ml reaction flask, and 1,4-dioxane (100 ml) and 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (8.28) were added. g, 34.5 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (0.56 g, 0.69 mmol) and aqueous cesium carbonate solution (50 ml, containing 33.72 g Barium carbonate, 103.5 mmol), heated to 70 ° C under nitrogen, reacted for 3 hours, and extracted with dichloromethane. The organic phase was separated and washed with brine, dried over anhydrous sodium sulfate, filtered, evaporated .
1H NMR(500MHz,DMSO-d6):δ8.9328(s,1H),8.2019(m,2H),7.7153(m,2H),7.5227(m,1H),5.1824(t,1H),4.7675(m,1H),4.4782(s,3H),4.1671(t,1H),3.9184(m,1H),3.7203(m,1H),3.6122(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ8.9328 (s, 1H), 8.2019 (m, 2H), 7.7153 (m, 2H), 7.5227 (m, 1H), 5.1824 (t, 1H), 4.7675 ( m, 1H), 4.4782 (s, 3H), 4.1671 (t, 1H), 3.9184 (m, 1H), 3.7203 (m, 1H), 3.6122 (m, 1H).
13C NMR(125MHz,DMSO-d6):δ163.75,159.1925,154.147,149.235,144.983,140.434,136.91,131.475,130.69,121.918,118.483,113.89,105.292,73.314,61.507,45.907,39.519。 13 C NMR (125 MHz, DMSO-d6): δ 163.75, 159.1925, 154.147, 149.235, 144.983, 140.434, 136.91, 131.475, 130.69, 121.918, 118.483, 113.89, 105.292, 73.314, 61.507, 45.907, 39.519.
ESI-MS[M+H]+:371.1264。ESI-MS [M+H] + : 371.1264.
步骤2 (R)-[3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)-3-氟苯基)-2-氧-5-唑烷基]甲基磷酸双(苄基酯)(式VII化合物)的制备Step 2 (R)-[3-(4-(2-(2-Methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-2-oxo-5-oxazolidinyl Preparation of bis(benzyl ester) methyl phosphate (compound of formula VII)
500ml三口瓶中加入二氯甲烷(100ml)、1H-四氮唑(5.97g,85.2mmol)和式V化合物(10.5g,28.4mmol),控温在30℃以下滴加二异丙胺基亚磷酸二苄酯(19.6g,56.8mmol),保持温度在25-30℃反应30min。降温至0-10℃,加入85%间氯过氧苯甲酸(8.08g,39.8mmol),5-10℃反应30min。Dichloromethane (100 ml), 1H-tetrazole (5.97 g, 85.2 mmol) and compound of formula V (10.5 g, 28.4 mmol) were added to a 500 ml three-necked flask, and diisopropylaminophosphoric acid was added dropwise at a temperature below 30 ° C. Dibenzyl ester (19.6 g, 56.8 mmol) was reacted for 30 min at 25-30 °C. The temperature was lowered to 0-10 ° C, 85% m-chloroperoxybenzoic acid (8.08 g, 39.8 mmol) was added, and the reaction was carried out at 5-10 ° C for 30 min.
反应液依次用饱和NaHCO3洗涤两次,饱和NaCl洗涤一次,无水硫酸钠干燥,过滤,浓缩,通过柱色谱纯化,得到14.89g标题化合物,收率83.1%,HPLC检测纯度为99.62%(面积归一化法)。The reaction solution was washed successively with saturated NaHCO 3 twice, washed once with saturated NaCl, dried over anhydrous sodium sulfate, filtered, concentrated and purified by column chromatography to give 14.89g of the title compound in a yield of 83.1%, HPLC purity by 99.62% (area Normalization method).
1H NMR(500MHz,DMSO-d6):δ8.9318(s,1H),8.241(m,1H),8.1938(m,1H),7.7457(t,1H),7.6669(1,1H),7.4924(1,1H),7.3442(1,10H),5.0336(1,5H),4.4859(s,3H),3.3063(m,3H),3.9175(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ8.9318 (s, 1H), 8.241 (m, 1H), 8.1938 (m, 1H), 7.7457 (t, 1H), 7.6669 (1,1H), 7.4924 ( 1,1H), 7.3442 (1,10H), 5.0336 (1,5H), 4.4859 (s, 3H), 3.3063 (m, 3H), 3.9175 (m, 1H).
13C NMR(125MHz,DMSO-d6):5163.811,159.234,153.752,149.343,145.068,140.087,137.079,135.778,131.5,130.75,128.358,127.733,122.037,118.804,114.055,105.463,70.977,68.741,67.288,45.698,39.53。 13 C NMR (125 MHz, DMSO-d6): 5163.811, 159.234, 153.752, 149.343, 145.068, 140.087, 137.079, 135.778, 131.5, 130.75, 128.358, 127.733, 122.037, 118.804, 114.055, 105.463, 70.977, 68.741, 67.288, 45.698 , 39.53.
ESI-MS[M+H]+:631.1852。ESI-MS [M+H] + : 631.1852.
步骤3 磷酸特地唑胺(式I化合物)的制备Step 3 Preparation of tertazolidin phosphate (compound of formula I)
2L反应瓶中加入甲醇(1000ml),式VII化合物(12.8g)和10%Pd/C(50%水,1.28g),50℃常压加氢反应12h,过滤,蒸干,得8.78g标题化合物,收率96.0%,HPLC检测纯度为99.66%(面积归一化法)。Methanol (1000 ml), a compound of formula VII (12.8 g) and 10% Pd/C (50% water, 1.28 g) were added to a 2 L reaction flask, and hydrogenated at 50 ° C for 12 h under normal pressure, filtered, and evaporated to give 8.78 g of title. The compound was obtained in a yield of 96.0%, and the purity by HPLC was 99.66% (area normalization method).
1H NMR(500MHz,DMSO-d6):δ8.9367(s,1H),8.2052(m,2H),7.72(m,2H),7.5162(m,1H),4.99(m,1H),4.4961(s,3H),4.2546(t,1H),4.1714(m,1H),4.1035(m,1H),3.9521(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ8.9367 (s, 1H), 8.2052 (m, 2H), 7.72 (m, 2H), 7.5162 (m, 1H), 4.99 (m, 1H), 4.4961 ( s, 3H), 4.2546 (t, 1H), 4.1714 (m, 1H), 4.1035 (m, 1H), 3.9521 (m, 1H).
13C NMR(125MHz,DMSO-d6):δ163.854,159.2905,153.925,149.382,145.069,140.286,137.083,131.558,130.87,122.044,118.764,114.079,105.509,71.467,65.457,45.833,39.549。 13 C NMR (125 MHz, DMSO-d6): δ 163.854, 159.2905, 153.925, 149.382, 145.069, 140.286, 137.083, 131.558, 130.87, 122.044, 118.764, 114.079, 105.509, 71.467, 65.457, 45.833, 39.549.
ESI-MS m/z[M+H]+:451.0927。ESI-MS m/z [M+H] + : 451.0927.
实施例2磷酸特地唑胺(式I化合物)的制备Example 2 Preparation of tertazolidin phosphate (compound of formula I)
步骤1 (R)-[3-(4-溴-3-氟苯基)-2-氧-5-唑烷基]甲基磷酸双(苄基酯)(式IX化合物)的制备Step 1 Preparation of (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester) (compound of formula IX)
250ml三口瓶中加入二氯甲烷(50ml),1H-四氮唑(7.24g,103.41mmol)和(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(10.0g,34.47mmol),控温在30℃以下滴加二异丙胺基亚磷酸二苄酯(23.81g,68.94mmol),保持温度在25-30℃反应30min,降温至0-10℃,加入85%间氯过氧苯甲酸(9.8g,48.26mmol),5-10℃反应30min。Dichloromethane (50 ml), 1H-tetrazole (7.24 g, 103.41 mmol) and (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazole were added to a 250 ml three-necked flask. Alkan-2-one (10.0 g, 34.47 mmol), dibenzyl diisopropylammonium phosphite (23.81 g, 68.94 mmol) was added dropwise at a temperature below 30 ° C, and the temperature was maintained at 25-30 ° C for 30 min, and the temperature was lowered. At 0-10 ° C, 85% m-chloroperoxybenzoic acid (9.8 g, 48.26 mmol) was added and the reaction was carried out at 5-10 ° C for 30 min.
反应液依次用饱和NaHCO3洗涤两次,饱和NaCl溶液洗涤一次,无水Na2SO4干燥,过滤,真空浓缩并通过柱色谱纯化,得到17.11g标题化合物,收率90.2%,HPLC检测纯度为99.24%(面积归一化法)。The reaction solution was washed successively with saturated NaHCO 3 twice, once with saturated NaCl solution and dried over anhydrous Na 2 SO 4, filtered, concentrated in vacuo and purified by column chromatography to afford 17.11g of the title compound in a yield of 90.2%, HPLC purity detection 99.24% (area normalization method).
1H NMR(500MHz,DMSO-d6):δ7.6892(m,1H),7.6387(dd,1H),7.3240(m,11H),5.034(m,4H),4.9644(m,1H),4.3203(m,1H),4.2576(m,1H),4.1594(m,1H),3.8409(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ7.6892 (m, 1H), 7.6387 (dd, 1H), 7.3240 (m, 11H), 5.034 (m, 4H), 4.9644 (m, 1H), 4.3203 ( m, 1H), 4.2576 (m, 1H), 4.1594 (m, 1H), 3.8409 (m, 1H).
13C NMR(125MHz,DMSO-d6):δ159.1,157.168,153.666,139.254,135.737,135.684,133.364,128.361,128.331,128.285,127.737,127.67,114.991,106.1081,70.899,68.744,68.703,67.201,45.652,39.499。 13 C NMR (125 MHz, DMSO-d6): δ 159.1, 157.168, 153.666, 139.254, 135.737, 135.684, 133.364, 128.361, 128.331, 128.285, 127.737, 127.67, 114.991, 106.1081, 70.899, 68.744, 68.703, 67.201, 45.652 , 39.499.
ESI-MS[M+H]+:550.0425。ESI-MS [M+H] + : 550.0425.
步骤2 B-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]硼酸(式X化合物)的制备Step 2 Preparation of B-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridyl]boronic acid (compound of formula X)
250ml反应瓶中加入DMSO(100ml),5-溴-2-(2-甲基-2H-四唑-5-基)吡啶(10.0g,41.66mmo1)、联硼酸频那醇酯(12.69g,49.99mmol)、[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物(1.7g,2.08mmol)和醋酸钾(16.35g,166.64mmol),N2保护下,升温至80℃,反应3h。二氯甲烷/水萃取,分离所得的有机相用饱和NaCl溶液洗涤、无水Na2SO4脱水、过滤、真空浓缩并通过柱色谱纯化,得到8.11g固体,收率95.0%,HPLC检测纯度为98.2%(面积归一化法)。To a 250 ml reaction flask was added DMSO (100 ml), 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (10.0 g, 41.66 mmol), and benzoic acid pinacol ester (12.69 g, 49.99 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (1.7 g, 2.08 mmol) and potassium acetate (16.35 g, 166.64 mmol), N Under the protection of 2 , the temperature was raised to 80 ° C and the reaction was carried out for 3 h. Methylene chloride / water extraction, the organic phase was washed with saturated NaCl solution resulting was separated, dried over anhydrous Na 2 SO 4 dried, filtered, concentrated in vacuo and purified by column chromatography to give 8.11g solid, yield 95.0%, HPLC purity detection 98.2% (area normalization method).
1H NMR(500MHz,DMSO-d6):δ8.9245(s,1H),8.2169(dd,1H),8.1549(dd,1H),4.4811(s,3H)。 1 H NMR (500 MHz, DMSO-d6): δ s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s
13C NMR(125MHz,DMSO-d6):5163.901,154.885,148.290,143.277,121.612,84.278,24.575。 13 C NMR (125 MHz, DMSO-d6): 5163.901, 154.885, 148.290, 143.277, 121.612, 84.278, 24.575.
ESI-MS[M+H]+:206.0845。ESI-MS [M+H] + : 206.0845.
步骤3 (R)-[3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯)(式VII化合物)的制备Step 3 (R)-[3-(4-(2-(2-Methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-2-oxo-5-oxazolidine Preparation of bis(benzyl ester) methyl phosphate (compound of formula VII)
250ml反应瓶中加入1,4-二氧六环(60m1)、式XII化合物(17.0g,30.89mmol)、式X化合物(6.97g,33.98mmol)、[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物(0.51g,0.62mmol)、碳酸钠水溶液(30ml,含10.8g碳酸钠,101.94mmol),N2保护下,升温至70℃,反应3h,加入二氯甲烷萃取,分离所得的有机相用饱和NaCl溶液洗涤、无水Na2SO4脱水、过滤、真空浓缩并通过柱色谱纯化,得到15.31g固体,收率78.6%,HPLC检测纯度为98.43%(面积归一化法)。1,4-dioxane (60 ml), a compound of formula XII (17.0 g, 30.89 mmol), a compound of formula X (6.97 g, 33.98 mmol), [1,1'-bis(diphenyl) were added to a 250 ml reaction flask. Phosphine) ferrocene] palladium dichloride dichloromethane complex (0.51 g, 0.62 mmol), aqueous sodium carbonate (30 ml, containing 10.8 g of sodium carbonate, 101.94 mmol), heated to 70 ° C under N 2 protection. After the reaction was carried out for 3 h, the mixture was extracted with methylene chloride, and the obtained organic phase was washed with a saturated NaCI solution, dried over anhydrous Na 2 SO 4 , filtered, concentrated in vacuo and purified by column chromatography to give 15.31 g of solid, yield 78. The purity was 98.43% (area normalization method).
1H NMR(500MHz,DMSO-d6):δ8.9318(s,1H),8.241(m,1H),8.1938(m,1H),7.7457(t,1H),7.6669(m,1H),7.4924(m,1H),7.3442(m,10H),5.0336(m,5H),4.4859(s,3H),3.3063(m,3H),3.9175(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ8.9318 (s, 1H), 8.241 (m, 1H), 8.1938 (m, 1H), 7.7457 (t, 1H), 7.6669 (m, 1H), 7.4924 ( m, 1H), 7.3442 (m, 10H), 5.0336 (m, 5H), 4.4859 (s, 3H), 3.3063 (m, 3H), 3.9175 (m, 1H).
13C NMR(125MHz,DMSO-d6):δ163.811,159.234,153.752,149.343,145.068,140.087,137.079,135.778,131.5,130.75,128.358,127.733,122.037,118.804,114.055,105.463,70.977,68.741,67.288,45.698,39.53。 13 C NMR (125 MHz, DMSO-d6): δ 163. 811, 159. 234, 153. 752, 149. 343, 145. 068, 140.087, 137.079, 135. 778, 131.5, 130.75, 128.358, 127.733, 122.037, 118.804, 114.055, 105.463, 70.977, 68.741, 67.288 , 45.698, 39.53.
ESI-MS[M+H]+:631.1852。ESI-MS [M+H] + : 631.1852.
步骤4 磷酸特地唑胺(式I化合物)的制备Step 4 Preparation of tertazolidin phosphate (compound of formula I)
2L反应瓶中加入甲醇(1000ml)、式VII化合物(12.0g)和10%Pd/C(50%水,1.2g),50℃常压加氢反应12h,过滤,真空浓缩,得8.21g标题化合物,收率95.8%,HPLC检测纯度为99.37%(面积归一化法)。Methanol (1000 ml), a compound of the formula VII (12.0 g) and 10% Pd/C (50% water, 1.2 g) were added to a 2 L reaction flask, and hydrogenation was carried out at 50 ° C for 12 h under normal pressure, filtered, and concentrated in vacuo to give 8.21. The compound was obtained in a yield of 95.8%, and the purity by HPLC was 99.37% (area normalization method).
1H NMR(500MHz,DMSO-d6):δ8.9367(s,1H),8.2052(m,2H),7.72(m,2H),7.5162(m,1H),4.99(m,1H),4.4961(s,3H),4.2546(t,1H),4.1714(m,1H),4.1035(m,1H),3.9521(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ8.9367 (s, 1H), 8.2052 (m, 2H), 7.72 (m, 2H), 7.5162 (m, 1H), 4.99 (m, 1H), 4.4961 ( s, 3H), 4.2546 (t, 1H), 4.1714 (m, 1H), 4.1035 (m, 1H), 3.9521 (m, 1H).
13C NMR(125MHz,DMSO-d6):δ163.854,159.2905,153.925,149.382,145.069,140.286,137.083,131.558,130.87,122.044,118.764,114.079,105.509,71.467,65.457,45.833,39.549。 13 C NMR (125 MHz, DMSO-d6): δ 163.854, 159.2905, 153.925, 149.382, 145.069, 140.286, 137.083, 131.558, 130.87, 122.044, 118.764, 114.079, 105.509, 71.467, 65.457, 45.833, 39.549.
ESI-MS m/z[M+H]+:451.0927。ESI-MS m/z [M+H] + : 451.0927.
实施例3磷酸特地唑胺(式I化合物)的制备Example 3 Preparation of tertazolidinyl phosphate (compound of formula I)
步骤1 B-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]硼酸(式X化合物)的制备Step 1 Preparation of B-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridyl]boronic acid (compound of formula X)
250ml反应瓶中加入DMSO(100ml),5-溴-2-(2-甲基-2H-四唑-5-基)吡啶(10.0g,41.66mmol)、联硼酸频那醇酯(12.69g,49.99mmol)、[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物(1.7g,2.08mmol)和醋酸钾(16.35g,166.64mmol),N2保护下,升温至80℃,反应3h。二氯甲烷/水萃取,分离所得的有机相用饱和NaCl溶液洗涤、无水Na2SO4脱水、过滤、真空浓缩并通过柱色谱纯化,得到8.11g固体,收率95.0%,HPLC检测纯度为98.2%(面积归一化法)。To a 250 ml reaction flask was added DMSO (100 ml), 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (10.0 g, 41.66 mmol), and benzoic acid pinacol ester (12.69 g, 49.99 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (1.7 g, 2.08 mmol) and potassium acetate (16.35 g, 166.64 mmol), N Under the protection of 2 , the temperature was raised to 80 ° C and the reaction was carried out for 3 h. Methylene chloride / water extraction, the organic phase was washed with saturated NaCl solution resulting was separated, dried over anhydrous Na 2 SO 4 dried, filtered, concentrated in vacuo and purified by column chromatography to give 8.11g solid, yield 95.0%, HPLC purity detection 98.2% (area normalization method).
1H NMR(500MHz,DMSO-d6):δ8.9245(s,1H),8.2169(dd,1H),8.1549(dd,1H),4.4811(s,3H)。 1 H NMR (500 MHz, DMSO-d6): δ s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s s
13C NMR(125MHz,DMSO-d6):δ163.901,154.885,148.290,143.277,121.612,84.278,24.575。 13 C NMR (125 MHz, DMSO-d6): δ 163. 901, 154. 885, 148.290, 143.277, 121.612, 84.278, 24.575.
ESI-MS[M+H]+:206.0845。 ESI-MS [M+H] + : 206.0845.
步骤2 (R)-3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)3-氟苯基)-5-羟甲基噁唑烷-2-酮(式V化合物)的制备Step 2 (R)-3-(4-(2-(2-Methyltetrazol-5-yl)pyridin-5-yl)3-fluorophenyl)-5-hydroxymethyloxazolidine-2- Preparation of ketones (compounds of formula V)
250ml反应瓶中加入1,4-二氧六环(100ml)、式X化合物(8g,39mmol)、(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(11.3g,39mmol)、[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物(0.64g,0.78mmol)和碳酸铯水溶液(60ml,含41.93g碳酸铯,128.7mmol),N2保护下,升温至70℃,反应3h,加入二氯甲烷萃取。分离所得的有机相用饱和NaCl溶液洗涤、无水Na2SO4脱水、过滤、真空浓缩并通过柱色谱纯化,得到12.16g固体,收率84.2%,HPLC检测纯度为98.39%(面积归一化法)。1,4-dioxane (100 ml), compound of formula X (8 g, 39 mmol), (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyl Oxazolidin-2-one (11.3 g, 39 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (0.64 g, 0.78 mmol) and cesium carbonate Aqueous solution (60 ml, containing 41.93 g of cesium carbonate, 128.7 mmol), and warmed to 70 ° C under N 2 and reacted for 3 h, and extracted with dichloromethane. The organic phase was washed with saturated NaCl solution resulting was separated, dried over anhydrous Na 2 SO 4 dried, filtered, concentrated in vacuo and purified by column chromatography to give 12.16g solid, yield 84.2%, HPLC purity of 98.39% is detected (area normalization law).
1H NMR(500MHz,DMSO-d6):δ8.9328(s,1H),8.2019(m,2H),7.7153(m,2H),7.5227(m,1H),5.1824(t,1H),4.7675(m,1H),4.4782(s,3H),4.1671(t,1H),3.9184(m,1H),3.7203(m,1H),3.6122(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ8.9328 (s, 1H), 8.2019 (m, 2H), 7.7153 (m, 2H), 7.5227 (m, 1H), 5.1824 (t, 1H), 4.7675 ( m, 1H), 4.4782 (s, 3H), 4.1671 (t, 1H), 3.9184 (m, 1H), 3.7203 (m, 1H), 3.6122 (m, 1H).
13C NMR(125MHz,DMSO-d6):δ163.75,159.1925,154.147,149.235,144.983,140.434,136.91,131.475,130.69,121.918,118.483,113.89,105.292,73.314,61.507,45.907,39.519。 13 C NMR (125 MHz, DMSO-d6): δ 163.75, 159.1925, 154.147, 149.235, 144.983, 140.434, 136.91, 131.475, 130.69, 121.918, 118.483, 113.89, 105.292, 73.314, 61.507, 45.907, 39.519.
ESI-MS[M+H]+:371.1264。ESI-MS [M+H] + : 371.1264.
步骤3 (R)-[3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯)(式VII化合物)的制备Step 3 (R)-[3-(4-(2-(2-Methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-2-oxo-5-oxazolidine Preparation of bis(benzyl ester) methyl phosphate (compound of formula VII)
500ml三口瓶中加入二氯甲烷(100ml)、1H-四氮唑(5.67g,81.0mmol)和式V化合物(10g,27.0mmol),控温在30℃以下滴加二异丙胺基亚磷酸二苄酯(18.65g,54.0mmol),保持温度在25-30℃反应30min。降温至0-10℃,加入85%间氯过氧苯甲酸(7.67g,37.8mmol),5-10℃反应30min。Dichloromethane (100 ml), 1H-tetrazole (5.67 g, 81.0 mmol) and the compound of formula V (10 g, 27.0 mmol) were added to a 500 ml three-necked flask, and diisopropylaminophosphite was added dropwise at a temperature below 30 ° C. Benzyl ester (18.65 g, 54.0 mmol) was reacted for 30 min at 25-30 °C. The temperature was lowered to 0-10 ° C, 85% m-chloroperoxybenzoic acid (7.67 g, 37.8 mmol) was added, and the reaction was carried out at 5-10 ° C for 30 min.
反应液依次用饱和NaHCO3溶液洗涤两次,饱和NaCl溶液洗涤一次,无水Na2SO4干燥,过滤,真空浓缩并通过柱色谱纯化,得到14.1g标题化合物,收率82.8%,HPLC检测纯度为99.49%(面积归一化法)。The reaction solution was washed successively with saturated NaHCO 3 solution twice, washed with a saturated NaCl solution, dried over anhydrous Na 2 SO 4, filtered, concentrated in vacuo and purified by column chromatography, to give 14.1g of the title compound in a yield of 82.8%, HPLC purity by It is 99.49% (area normalization method).
1H NMR(500MHz,DMSO-d6):δ8.9318(s,1H),8.241(m,1H),8.1938(m,1H),7.7457(t,1H),7.6669(m,1H),7.4924(m,1H),7.3442(m,10H),5.0336(m,5H),4.4859(s,3H),3.3063(m,3H),3.9175(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ8.9318 (s, 1H), 8.241 (m, 1H), 8.1938 (m, 1H), 7.7457 (t, 1H), 7.6669 (m, 1H), 7.4924 ( m, 1H), 7.3442 (m, 10H), 5.0336 (m, 5H), 4.4859 (s, 3H), 3.3063 (m, 3H), 3.9175 (m, 1H).
13C NMR(125MHz,DMSO-d6):δ163.811,159.234,153.752,149.343,145.068,140.087,137.079,135.778,131.5,130.75,128.358,127.733,122.037,118.804,114.055,105.463,70.977,68.741,67.288,45.698,39.53。 13 C NMR (125 MHz, DMSO-d6): δ 163. 811, 159. 234, 153. 752, 149. 343, 145. 068, 140.087, 137.079, 135. 778, 131.5, 130.75, 128.358, 127.733, 122.037, 118.804, 114.055, 105.463, 70.977, 68.741, 67.288 , 45.698, 39.53.
ESI-MS[M+H]+:631.1852。ESI-MS [M+H] + : 631.1852.
步骤4 磷酸特地唑胺(式I化合物)的制备Step 4 Preparation of tertazolidin phosphate (compound of formula I)
2L反应瓶中加入甲醇(1000ml),式VII化合物(12g,19mmol)和10%Pd/C(50%水,1.2g),50℃常压加氢反应12h,过滤,真空浓缩,得8.22g标题化合物,收率96.1%,HPLC检测纯度为99.51%(面积归一化法)。Methanol (1000 ml), a compound of the formula VII (12 g, 19 mmol) and 10% Pd/C (50% water, 1.2 g) were added to a 2 L reaction flask, and hydrogenated at 50 ° C for 12 h under normal pressure, filtered, and concentrated in vacuo to give 8.22 g. The title compound, yield 96.1%, was found to be 99.51% by HPLC (area normalization).
1H NMR(500MHz,DMSO-d6):δ8.9367(s,1H),8.2052(m,2H),7.72(m,2H),7.5162(m,1H),4.99(m,1H),4.4961(s,3H),4.2546(t,1H),4.1714(m,1H),4.1035(m,1H),3.9521(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ8.9367 (s, 1H), 8.2052 (m, 2H), 7.72 (m, 2H), 7.5162 (m, 1H), 4.99 (m, 1H), 4.4961 ( s, 3H), 4.2546 (t, 1H), 4.1714 (m, 1H), 4.1035 (m, 1H), 3.9521 (m, 1H).
13C NMR(125MHz,DMSO-d6):δ163.854,159.2905,153.925,149.382,145.069,140.286,137.083, 131.558,130.87,122.044,118.764,114.079,105.509,71.467,65.457,45.833,39.549。 13 C NMR (125 MHz, DMSO-d6): δ 163.854, 159.2905, 153.925, 149.382, 145.069, 140.286, 137.083, 131.558, 130.87, 122.044, 118.764, 114.079, 105.509, 71.467, 65.457, 45.833, 39.549.
ESI-MS m/z[M+H]+:451.0927。ESI-MS m/z [M+H] + : 451.0927.
实施例4磷酸特地唑胺(式I化合物)的制备Example 4 Preparation of tertazolidinyl phosphate (compound of formula I)
步骤1 (R)-3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)3-氟苯基)-5-羟甲基噁唑烷-2-酮(式V化合物)的制备Step 1 (R)-3-(4-(2-(2-Methyltetrazol-5-yl)pyridin-5-yl)3-fluorophenyl)-5-hydroxymethyloxazolidine-2- Preparation of ketones (compounds of formula V)
250ml反应瓶中加入DMSO(100ml),(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(10g,34.5mmol)、联硼酸频那醇酯(17.52g,69mmol)、[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物(1.41g,1.73mmol)和醋酸钾(13.5g,138mmol),氮气保护下,升温至80℃,反应14小时。停止加热,降至室温,水/乙酸乙酯萃取3次,合并有机层,有机层用饱和食盐水洗涤3次,无水硫酸钠干燥,抽滤浓缩。DMSO (100 ml), (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (10 g, 34.5 mmol), boronic acid frequency was added to a 250 ml reaction flask. Alcohol ester (17.52 g, 69 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (1.41 g, 1.73 mmol) and potassium acetate (13.5 g) , 138 mmol), heated to 80 ° C under nitrogen, and reacted for 14 hours. The heating was stopped, the temperature was lowered to room temperature, and the mixture was combined with water and ethyl acetate. The organic layer was combined and evaporated.
将上述步骤的浓缩产物加入到250ml反应瓶中,加入1,4-二氧六环(100ml)、5-溴-2-(2-甲基-2H-四唑-5-基)吡啶(8.28g,34.5mmol)、[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物(0.56g,0.69mmol)和碳酸铯水溶液(50ml,含33.72g碳酸铯,103.5mmol),氮气保护下,升温至70℃,反应3小时,加入二氯甲烷萃取。分离所得的有机相用饱和食盐水洗涤、无水硫酸钠脱水、过滤、真空浓缩并通过柱色谱纯化,得到10.6g固体,收率83.0%,HPLC检测纯度为98.34%(面积归一化法)。The concentrated product of the above step was added to a 250 ml reaction flask, and 1,4-dioxane (100 ml) and 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (8.28) were added. g, 34.5 mmol), [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex (0.56 g, 0.69 mmol) and aqueous cesium carbonate solution (50 ml, containing 33.72 g Barium carbonate, 103.5 mmol), heated to 70 ° C under nitrogen, reacted for 3 hours, and extracted with dichloromethane. The organic phase was separated and washed with brine, dried over anhydrous sodium sulfate, filtered, evaporated .
1H NMR(500MHz,DMSO-d6):δ8.9328(s,1H),8.2019(m,2H),7.7153(m,2H),7.5227(m,1H),5.1824(t,1H),4.7675(m,1H),4.4782(s,3H),4.1671(t,1H),3.9184(m,1H),3.7203(m,1H),3.6122(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ8.9328 (s, 1H), 8.2019 (m, 2H), 7.7153 (m, 2H), 7.5227 (m, 1H), 5.1824 (t, 1H), 4.7675 ( m, 1H), 4.4782 (s, 3H), 4.1671 (t, 1H), 3.9184 (m, 1H), 3.7203 (m, 1H), 3.6122 (m, 1H).
13C NMR(125MHz,DMSO-d6):δ163.75,159.1925,154.147,149.235,144.983,140.434,136.91,131.475,130.69,121.918,118.483,113.89,105.292,73.314,61.507,45.907,39.519。 13 C NMR (125 MHz, DMSO-d6): δ 163.75, 159.1925, 154.147, 149.235, 144.983, 140.434, 136.91, 131.475, 130.69, 121.918, 118.483, 113.89, 105.292, 73.314, 61.507, 45.907, 39.519.
ESI-MS[M+H]+:371.1264。ESI-MS [M+H] + : 371.1264.
步骤2 (R)-[3-(4-(2-(2-甲基四唑-5-基)吡啶-5-基)-3-氟苯基)-2-氧-5-唑烷基]甲基磷酸双(苄基酯)(式VII化合物)的制备Step 2 (R)-[3-(4-(2-(2-Methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-2-oxo-5-oxazolidinyl Preparation of bis(benzyl ester) methyl phosphate (compound of formula VII)
500ml三口瓶中加入二氯甲烷(100ml)、1H-四氮唑(5.97g,85.2mmol)和式V化合物(10.5g,28.4mmol),控温在30℃以下滴加二异丙胺基亚磷酸二苄酯(19.6g,56.8mmol),保持温度在25-30℃反应30min。降温至0-10℃,加入85%间氯过氧苯甲酸(8.08g,39.8mmol),5-10℃反应30min。Dichloromethane (100 ml), 1H-tetrazole (5.97 g, 85.2 mmol) and compound of formula V (10.5 g, 28.4 mmol) were added to a 500 ml three-necked flask, and diisopropylaminophosphoric acid was added dropwise at a temperature below 30 ° C. Dibenzyl ester (19.6 g, 56.8 mmol) was reacted for 30 min at 25-30 °C. The temperature was lowered to 0-10 ° C, 85% m-chloroperoxybenzoic acid (8.08 g, 39.8 mmol) was added, and the reaction was carried out at 5-10 ° C for 30 min.
反应液依次用饱和NaHCO3洗涤两次,饱和NaCl洗涤一次,无水硫酸钠干燥,过滤,浓缩,通过柱色谱纯化,得到14.89g标题化合物,收率83.1%,HPLC检测纯度为99.62%(面积归一化法)。The reaction solution was washed successively with saturated NaHCO 3 twice, washed once with saturated NaCl, dried over anhydrous sodium sulfate, filtered, concentrated and purified by column chromatography to give 14.89g of the title compound in a yield of 83.1%, HPLC purity by 99.62% (area Normalization method).
1H NMR(500MHz,DMSO-d6):δ8.9318(s,1H),8.241(m,1H),8.1938(m,1H),7.7457(t,1H),7.6669(m,1H),7.4924(m,1H),7.3442(m,10H),5.0336(m,5H),4.4859(s,3H),3.3063(m,3H),3.9175(m,1H)。 1 H NMR (500MHz, DMSO- d6): δ8.9318 (s, 1H), 8.241 (m, 1H), 8.1938 (m, 1H), 7.7457 (t, 1H), 7.6669 (m, 1H), 7.4924 ( m, 1H), 7.3442 (m, 10H), 5.0336 (m, 5H), 4.4859 (s, 3H), 3.3063 (m, 3H), 3.9175 (m, 1H).
13C NMR(125MHz,DMSO-d6):δ163.811,159.234,153.752,149.343,145.068,140.087,137.079,135.778,131.5,130.75,128.358,127.733,122.037,118.804,114.055,105.463,70.977,68.741,67.288,45.698,39.53。 13 C NMR (125 MHz, DMSO-d6): δ 163. 811, 159. 234, 153. 752, 149. 343, 145. 068, 140.087, 137.079, 135. 778, 131.5, 130.75, 128.358, 127.733, 122.037, 118.804, 114.055, 105.463, 70.977, 68.741, 67.288 , 45.698, 39.53.
ESI-MS[M+H]+:631.1852。 ESI-MS [M+H] + : 631.1852.
步骤3 磷酸特地唑胺(式I化合物)的制备Step 3 Preparation of tertazolidin phosphate (compound of formula I)
500ml反应瓶中加入二氯甲烷(50ml),三氟乙酸(55ml),式VII化合物(12g),40-45℃,搅拌溶解,反应16小时。40-45℃减压浓缩至无液体流出,加入80ml无水乙醇搅拌3小时,过滤,滤饼用18ml无水乙醇洗涤,滤饼于40-45℃真空干燥16小时,得8.14g标题化合物,收率95.0%,HPLC检测纯度为99.23%(面积归一化法)。Methylene chloride (50 ml), trifluoroacetic acid (55 ml), a compound of the formula VII (12 g), 40-45 ° C, were dissolved in a 500 ml reaction flask, and the mixture was stirred for 16 hours. The mixture was concentrated under reduced pressure at 40-45 ° C to dryness eluting with EtOAc (EtOAc). The yield was 95.0%, and the purity by HPLC was 99.23% (area normalization method).
1H NMR(500MHz,DMSO-d6):58.9367(s,1H),8.2052(m,2H),7.72(m,2H),7.5162(m,1H),4.99(m,1H),4.4961(s,3H),4.2546(t,1H),4.1714(m,1H),4.1035(m,1H),3.9521(m,1H)。 1 H NMR (500MHz, DMSO- d6): 58.9367 (s, 1H), 8.2052 (m, 2H), 7.72 (m, 2H), 7.5162 (m, 1H), 4.99 (m, 1H), 4.4961 (s, 3H), 4.2546 (t, 1H), 4.1714 (m, 1H), 4.1035 (m, 1H), 3.9521 (m, 1H).
13C NMR(125MHz,DMSO-d6):5163.854,159.2905,153.925,149.382,145.069,140.286,137.083,131.558,130.87,122.044,118.764,114.079,105.509,71.467,65.457,45.833,39.549。 13 C NMR (125 MHz, DMSO-d6): 5163.854, 159.2905, 153.925, 149.382, 145.069, 140.286, 137.083, 131.558, 130.87, 122.044, 118.764, 114.079, 105.509, 71.467, 65.457, 45.833, 39.549.
ESI-MS m/z[M+H]+:451.0927。 ESI-MS m/z [M+H] + : 451.0927.

Claims (26)

  1. 一种式I化合物的方法的制备方法,所述方法包括:将式VII化合物进行如下脱除苄基的反应:A process for the preparation of a process of a compound of formula I, which comprises reacting a compound of formula VII with a benzyl group as follows:
    Figure PCTCN2015089820-appb-100001
    Figure PCTCN2015089820-appb-100001
  2. 如权利要求1所述的方法,其中,所述脱除苄基的反应在催化剂和氢源存在下进行,The method of claim 1 wherein said benzyl removal reaction is carried out in the presence of a catalyst and a hydrogen source,
    Figure PCTCN2015089820-appb-100002
    Figure PCTCN2015089820-appb-100002
    其中,所述催化剂选自Pd(OH)2/C、Pd/C、PdCl2、Pd(OAc)2、Pd(OH)2或Raney镍,优选为Pd/C,Wherein the catalyst is selected from the group consisting of Pd(OH) 2 /C, Pd/C, PdCl 2 , Pd(OAc) 2 , Pd(OH) 2 or Raney nickel, preferably Pd/C,
    其中,所述氢源选自H2、HCOOH、HCOONH4、NH2NH2或环己烯,优选为H2Wherein the hydrogen source is selected from the group consisting of H 2 , HCOOH, HCOONH 4 , NH 2 NH 2 or cyclohexene, preferably H 2 ,
    其中,反应溶剂选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂,优选为选自于由乙酸乙酯、乙酸丁酯和C1-C8的醇所组成的组中的一种溶剂或几种溶剂的混合溶剂,最优选为选自于由乙酸乙酯、甲醇和乙醇所组成的组中的一种溶剂或几种溶剂的混合溶剂,特别优选为甲醇。Wherein the reaction solvent is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, and a solvent or a mixed solvent of several solvents in a group consisting of ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO, preferably a solvent selected from the group consisting of ethyl acetate, butyl acetate and C 1 -C 8 alcohol or a mixed solvent of several solvents, most preferably selected from the group consisting of ethyl acetate, methanol and A solvent or a mixed solvent of several solvents in the group consisting of ethanol is particularly preferably methanol.
  3. 如权利要求1所述的方法,所述脱除苄基的反应在三氟乙酸的存在下进行,The method of claim 1, wherein the benzyl removal reaction is carried out in the presence of trifluoroacetic acid,
    Figure PCTCN2015089820-appb-100003
    Figure PCTCN2015089820-appb-100003
    其中,反应溶剂选自于由二氯甲烷、三氯甲烷、四氯化碳、水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂,优选为二氯甲烷;优选地,所述方法包括将反应产物用有机溶剂纯化的步骤。Wherein, the reaction solvent is selected from the group consisting of dichloromethane, chloroform, carbon tetrachloride, water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, Acetone, butanone, pentanone, cyclopentanone, ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO A solvent or a mixed solvent of several solvents, preferably dichloromethane; preferably, the method includes a step of purifying the reaction product with an organic solvent.
  4. 如权利要求1-3任一项所述的方法,所述方法还包括:式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应以制备所述VII化合物, The method according to any one of claims 1 to 3, further comprising: reacting a compound of the formula V and a compound of the formula VI in the presence of a catalyst or an oxidizing agent to prepare the compound of the VII,
    Figure PCTCN2015089820-appb-100004
    Figure PCTCN2015089820-appb-100004
    其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者,R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者,R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基,优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基,Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or, R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy substituted benzyl, preferably R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl,
    其中,所述催化剂选自1H-四氮唑或
    Figure PCTCN2015089820-appb-100005
    优选为1H-四氮唑,
    Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
    Figure PCTCN2015089820-appb-100005
    Preferred is 1H-tetrazole,
    其中,所述氧化剂选自于间氯过氧苯甲酸、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢,优选为间氯过氧苯甲酸,Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
    其中,反应溶剂选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂,优选为二氯甲烷,Wherein the reaction solvent is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, and a solvent or a mixed solvent of several solvents in a group consisting of ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO, preferably For methylene chloride,
    其中,式VI化合物优选为二异丙氨基亚磷酸二苄酯。Among them, the compound of the formula VI is preferably dibenzyl diisopropylaminophosphite.
  5. 如权利要求4所述的制备方法,其中,所述方法还包括:按照如下步骤制备所述式V化合物:The production method according to claim 4, wherein the method further comprises: preparing the compound of the formula V according to the following steps:
    (1)式III化合物与硼化试剂在钯催化剂和碱存在下进行反应,(1) a compound of the formula III is reacted with a borating reagent in the presence of a palladium catalyst and a base,
    (2)步骤(1)的产物与式IV化合物在钯催化剂和碱存在下进行反应,(2) the product of step (1) is reacted with a compound of formula IV in the presence of a palladium catalyst and a base,
    Figure PCTCN2015089820-appb-100006
    Figure PCTCN2015089820-appb-100006
    其中,X1和X2各自独立地选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,所述步骤(1)的硼化试剂选自于联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100007
    Figure PCTCN2015089820-appb-100008
    三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100009
    更 优选为联硼酸频那醇酯,
    Wherein the borating agent of the step (1) is selected from the group consisting of pinacol borate,
    Figure PCTCN2015089820-appb-100007
    Figure PCTCN2015089820-appb-100008
    Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
    Figure PCTCN2015089820-appb-100009
    More preferably, it is a benzoic acid pinacol ester,
    其中,所述步骤(1)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
    其中,所述步骤(1)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾,Wherein said base in step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium,
    其中,所述步骤(2)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst of the step (2) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
    其中,所述步骤(2)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Wherein the base of the step (2) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide and lithium diisopropylamide from C 1 -C 8 . One or more of the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine Preferred is potassium acetate.
  6. 如权利要求4所述的制备方法,其中,所述方法还包括:式X化合物与式III化合物在钯催化剂和碱存在下进行反应制备所述式V化合物,The process according to claim 4, wherein the method further comprises: reacting a compound of the formula X with a compound of the formula III in the presence of a palladium catalyst and a base to prepare the compound of the formula V,
    Figure PCTCN2015089820-appb-100010
    Figure PCTCN2015089820-appb-100010
    其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    式III化合物优选为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基
    Figure PCTCN2015089820-appb-100011
    唑烷-2-酮(式VIII),
    The compound of formula III is preferably (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyl
    Figure PCTCN2015089820-appb-100011
    Oxazol-2-one (formula VIII),
    Figure PCTCN2015089820-appb-100012
    Figure PCTCN2015089820-appb-100012
    其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
    其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸铯,Wherein the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably carbonic acid cesium,
    其中,反应溶剂为选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组中的一种溶剂或几种溶剂的混合溶剂, Wherein, the reaction solvent is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, a solvent or a mixture of several solvents in the group consisting of ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO, and NMP Solvent,
    其中,式V化合物的制备在N2或Ar的保护下进行。Among them, the preparation of the compound of the formula V is carried out under the protection of N 2 or Ar.
  7. 如权利要求1-3任一项所述的方法,所述方法还包括:式IX化合物与式X化合物在钯催化剂和碱存在下进行反应以制备所述式VII化合物,The method according to any one of claims 1 to 3, further comprising reacting a compound of the formula IX with a compound of the formula X in the presence of a palladium catalyst and a base to prepare the compound of the formula VII,
    Figure PCTCN2015089820-appb-100013
    Figure PCTCN2015089820-appb-100013
    其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
    其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸钠或碳酸钾,最优选为碳酸钠,Wherein the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably carbonic acid Sodium or potassium carbonate, most preferably sodium carbonate,
    其中,式IX化合物优选为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-
    Figure PCTCN2015089820-appb-100014
    唑烷基]甲基磷酸双(苄基酯)。
    Wherein the compound of the formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-
    Figure PCTCN2015089820-appb-100014
    Azolidinyl] bis(benzyl ester) methyl phosphate.
  8. 权利要求7所述的制备方法,其中,所述方法还包括:式III化合物和式VI化合物在催化剂、氧化剂存在下进行反应以制备所述式IX化合物,The process according to claim 7, wherein the method further comprises: reacting a compound of the formula III and a compound of the formula VI in the presence of a catalyst or an oxidizing agent to prepare the compound of the formula IX,
    Figure PCTCN2015089820-appb-100015
    Figure PCTCN2015089820-appb-100015
    其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基,优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基,Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy-substituted benzyl group, preferably at the same time R 1 and R 2 is isopropyl or ethyl, most preferably R 1 and R 2 simultaneously isopropyl,
    其中,所述催化剂选自于1H-四氮唑或
    Figure PCTCN2015089820-appb-100016
    优选为1H-四氮唑,
    Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
    Figure PCTCN2015089820-appb-100016
    Preferred is 1H-tetrazole,
    其中,所述氧化剂选自于间氯过氧苯甲酸、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢,优选为间氯过氧苯甲酸,Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
    其中,式IX化合物优选为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-
    Figure PCTCN2015089820-appb-100017
    唑烷基]甲基磷酸双(苄基酯),式III 化合物优选为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基
    Figure PCTCN2015089820-appb-100018
    唑烷-2-酮。
    Wherein the compound of the formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-
    Figure PCTCN2015089820-appb-100017
    Azolidyl] bis(benzyl ester) methyl phosphate, the compound of formula III is preferably (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyl
    Figure PCTCN2015089820-appb-100018
    Azolidin-2-one.
  9. 权利要求7或8所述的制备方法,其中,所述方法还包括:式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应以制备所述式X化合物,The production method according to claim 7 or 8, wherein the method further comprises: reacting a compound of the formula IV with a borating agent in the presence of a palladium catalyst and a base to prepare the compound of the formula X,
    Figure PCTCN2015089820-appb-100019
    Figure PCTCN2015089820-appb-100019
    其中,X2选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,所述硼化试剂选自于联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100020
    Figure PCTCN2015089820-appb-100021
    三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100022
    更优选为联硼酸频那醇酯,
    Wherein the borating agent is selected from the group consisting of pinacol borate,
    Figure PCTCN2015089820-appb-100020
    Figure PCTCN2015089820-appb-100021
    Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
    Figure PCTCN2015089820-appb-100022
    More preferably, it is a benzoic acid pinacol ester,
    其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
    其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Wherein the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium.
  10. 如权利要求2或7所述的制备方法,所述方法包括如下步骤:The preparation method according to claim 2 or 7, the method comprising the steps of:
    (1)式IX化合物与式X化合物在钯催化剂和碱存在下进行反应制备式VII化合物,(1) a compound of the formula IX is reacted with a compound of the formula X in the presence of a palladium catalyst and a base to prepare a compound of the formula VII,
    (2)式VII化合物在催化剂和氢源存在下进行反应制备式I化合物,(2) a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
    Figure PCTCN2015089820-appb-100023
    Figure PCTCN2015089820-appb-100023
    其中,所述催化剂、氢源的定义同权利要求2的记载,所述X1、钯催化剂、碱和式IX化合物的定义同权利要求7的记载。 Here, the definition of the catalyst and the hydrogen source is the same as the description of claim 2, and the definitions of the X 1 , the palladium catalyst, the base and the compound of the formula IX are as described in claim 7 .
  11. 如权利要求2、4和5任一项所述的制备方法,所述方法包括如下步骤:The preparation method according to any one of claims 2, 4 and 5, comprising the steps of:
    i)式III化合物与硼化试剂在钯催化剂和碱存在下进行反应,i) reacting a compound of formula III with a boronating reagent in the presence of a palladium catalyst and a base,
    ii)步骤i)的产物与式IV化合物在钯催化剂和碱存在下进行反应制备式V化合物,Ii) reacting the product of step i) with a compound of formula IV in the presence of a palladium catalyst and a base to prepare a compound of formula V,
    iii)式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应制备式VII化合物,Iii) a compound of the formula V and a compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent to prepare a compound of the formula VII,
    iv)式VII化合物在催化剂和氢源存在下进行反应制备式I化合物,Iv) a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
    Figure PCTCN2015089820-appb-100024
    Figure PCTCN2015089820-appb-100024
    其中,上述反应式第一步中的所述X1、X2、硼化试剂、钯催化剂、碱的定义同权利要求5所述;上述反应式第二步中的所述催化剂、氧化剂、R1和R2的定义同权利要求4所述;上述反应式第三步中的所述催化剂、氢源的定义同权利要求2所述。Wherein the X 1 , X 2 , the borating agent, the palladium catalyst, and the base in the first step of the above reaction formula are as defined in claim 5; the catalyst, the oxidizing agent, and the R in the second step of the above reaction formula. 1 and R 2 are as defined in claim 4; the catalyst and hydrogen source in the third step of the above reaction formula are as defined in claim 2.
  12. 如权利要求2、7、8和9任一项所述的制备方法,所述方法包括如下步骤:The preparation method according to any one of claims 2, 7, 8, and 9, the method comprising the steps of:
    i)式III化合物和式VI化合物在催化剂、氧化剂存在下进行反应制备式IX化合物,i) a compound of the formula III and a compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent to prepare a compound of the formula IX,
    ii)式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应制备式X化合物,Ii) a compound of the formula IV is reacted with a boronating reagent in the presence of a palladium catalyst and a base to prepare a compound of the formula X,
    iii)式IX化合物与式X化合物在钯催化剂和碱存在下进行反应制备式VII化合物,Iii) a compound of the formula IX is reacted with a compound of the formula X in the presence of a palladium catalyst and a base to prepare a compound of the formula VII,
    iv)式VII化合物在催化剂和氢源存在下进行反应制备式I化合物,Iv) a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
    Figure PCTCN2015089820-appb-100025
    Figure PCTCN2015089820-appb-100025
    其中,制备所述式IX化合物的步骤中的所述X1、催化剂、氧化剂、R1、R2和式IX化合物的定义同权利要求8所述;制备式X化合物的步骤中的所述X2、硼化试剂、钯催化剂、碱的定义同权利要求 9所述;制备式VII化合物的步骤中的钯催化剂、碱的定义同权利要求7所述;制备所述化合物I的步骤中的所述催化剂、氢源的定义同权利要求2所述。Wherein the X 1 , the catalyst, the oxidizing agent, the R 1 , the R 2 and the compound of the formula IX in the step of preparing the compound of the formula IX are as defined in claim 8; the X in the step of preparing the compound of the formula X 2 , a boration reagent, a palladium catalyst, a base are defined as claimed in claim 9; a palladium catalyst, a base in the step of preparing a compound of the formula VII, a base as defined in claim 7; in the step of preparing the compound I The definition of the catalyst and hydrogen source is as defined in claim 2.
  13. 如权利要求2、4、6任一项所述的制备方法,所述方法包括如下步骤:The preparation method according to any one of claims 2, 4, or 6, wherein the method comprises the steps of:
    (1)式X化合物与式III化合物在钯催化剂和碱存在下进行反应制备式V化合物,(1) a compound of the formula X is reacted with a compound of the formula III in the presence of a palladium catalyst and a base to prepare a compound of the formula V,
    (2)式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应制备式VII化合物,(2) a compound of the formula V and a compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent to prepare a compound of the formula VII,
    (3)式VII化合物在催化剂和氢源存在下进行反应制备式I化合物,(3) a compound of the formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of the formula I,
    Figure PCTCN2015089820-appb-100026
    Figure PCTCN2015089820-appb-100026
    其中,上述反应式第一步中的所述X1、钯催化剂、碱的定义同权利要求6所述;上述反应式第二步中的所述催化剂、氧化剂、R1和R2的定义同权利要求4所述;上述反应式第三步中的所述催化剂、氢源的定义同权利要求2所述。Wherein the definition of the X 1 , the palladium catalyst and the base in the first step of the above reaction formula is the same as defined in claim 6; the catalyst, the oxidizing agent, R 1 and R 2 in the second step of the above reaction formula are the same as defined in The catalyst and the hydrogen source in the third step of the above reaction formula are as defined in claim 2.
  14. 如权利要求2、4、6和9任一项所述的制备方法,所述方法包括如下步骤:The preparation method according to any one of claims 2, 4, 6 and 9, comprising the steps of:
    i)式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应制备式X化合物,i) a compound of the formula IV is reacted with a boronating reagent in the presence of a palladium catalyst and a base to prepare a compound of the formula X,
    ii)式X化合物与式III化合物在钯催化剂和碱存在下进行反应制备式V化合物,Ii) a compound of the formula X is reacted with a compound of the formula III in the presence of a palladium catalyst and a base to prepare a compound of the formula V,
    iii)式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应制备式VII化合物,Iii) a compound of the formula V and a compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent to prepare a compound of the formula VII,
    iv)式VII化合物在催化剂和氢源存在下进行反应制备式I化合物,Iv) a compound of formula VII is prepared by reacting a catalyst with a hydrogen source to prepare a compound of formula I,
    Figure PCTCN2015089820-appb-100027
    Figure PCTCN2015089820-appb-100027
    其中,上述反应式第一步中的所述X2、硼化试剂、钯催化剂、碱的定义同权利要求9所述;上述反应式第二步中的所述X1、钯催化剂、碱的定义同权利要求6所述;上述反应式第三步中的所述催化剂、氧化剂、R1和R2的定义同权利要求4所述;上述反应式第四步中的所述催化剂、氢源的定义同权利要求2所述。 Wherein the X 2 , the borating agent, the palladium catalyst, and the base in the first step of the above reaction formula are as defined in claim 9; the X 1 , the palladium catalyst, and the alkali in the second step of the above reaction formula. The definition is the same as claim 6; the catalyst, the oxidizing agent, R 1 and R 2 in the third step of the above reaction formula are as defined in claim 4; the catalyst and hydrogen source in the fourth step of the above reaction formula; The definition is the same as in claim 2.
  15. 如权利要求3、4和5任一项所述的制备方法,所述方法包括如下步骤:The preparation method according to any one of claims 3, 4 and 5, comprising the steps of:
    i)式III化合物与硼化试剂在钯催化剂和碱存在下进行反应,i) reacting a compound of formula III with a boronating reagent in the presence of a palladium catalyst and a base,
    ii)步骤i)的产物与式IV化合物在钯催化剂和碱存在下进行反应制备式V化合物,Ii) reacting the product of step i) with a compound of formula IV in the presence of a palladium catalyst and a base to prepare a compound of formula V,
    iii)式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应制备式VII化合物,Iii) a compound of the formula V and a compound of the formula VI are reacted in the presence of a catalyst or an oxidizing agent to prepare a compound of the formula VII,
    iv)式VII化合物在三氟乙酸存在下进行反应制备式I化合物,Iv) a compound of formula VII is reacted in the presence of trifluoroacetic acid to prepare a compound of formula I,
    Figure PCTCN2015089820-appb-100028
    Figure PCTCN2015089820-appb-100028
    其中,反应式第一步中的所述X1、X2、硼化试剂、钯催化剂、碱的定义同权利要求5所述;反应式第二步中的所述催化剂、氧化剂、R1和R2的定义同权利要求4所述。Wherein the X 1 , X 2 , the borating agent, the palladium catalyst, and the base in the first step of the reaction formula are as defined in claim 5; the catalyst, the oxidizing agent, the R 1 and the second step in the reaction formula; R 2 is as defined in claim 4.
  16. 中间体式VII化合物,Intermediate compound of formula VII,
    Figure PCTCN2015089820-appb-100029
    Figure PCTCN2015089820-appb-100029
  17. 如权利要求16所述的式VII化合物的制备方法,所述方法包括:式V化合物和式VI化合物在催化剂、氧化剂存在下进行反应以制备所述式VII化合物,A process for the preparation of a compound of formula VII according to claim 16 which comprises reacting a compound of formula V and a compound of formula VI in the presence of a catalyst, an oxidizing agent to prepare said compound of formula VII,
    Figure PCTCN2015089820-appb-100030
    Figure PCTCN2015089820-appb-100030
    其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者,R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者, R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基,优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基,Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or, R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or, R 1 and R 2 are each independently selected from halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy substituted benzyl, preferably R 1 and R 2 are both isopropyl or ethyl, most preferably R 1 and R 2 are both isopropyl,
    其中,所述催化剂选自1H-四氮唑或
    Figure PCTCN2015089820-appb-100031
    优选为1H-四氮唑,
    Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
    Figure PCTCN2015089820-appb-100031
    Preferred is 1H-tetrazole,
    其中,所述氧化剂选自于间氯过氧苯甲酸、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢,优选为间氯过氧苯甲酸,Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
    其中,反应溶剂选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC和DMSO所组成的组中的一种溶剂或几种溶剂的混合溶剂,优选为二氯甲烷,Wherein the reaction solvent is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, cyclopentanone, and a solvent or a mixed solvent of several solvents in a group consisting of ketone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC and DMSO, preferably For methylene chloride,
    其中,式VI化合物优选为二异丙氨基亚磷酸二苄酯。Among them, the compound of the formula VI is preferably dibenzyl diisopropylaminophosphite.
  18. 如权利要求17所述的方法,所述方法还包括:按照如下步骤制备所述式V化合物:The method of claim 17 further comprising: preparing said compound of formula V as follows:
    (1)式III化合物与硼化试剂在钯催化剂和碱存在下进行反应,(1) a compound of the formula III is reacted with a borating reagent in the presence of a palladium catalyst and a base,
    (2)步骤(1)的产物与式IV化合物在钯催化剂和碱存在下进行反应,(2) the product of step (1) is reacted with a compound of formula IV in the presence of a palladium catalyst and a base,
    Figure PCTCN2015089820-appb-100032
    Figure PCTCN2015089820-appb-100032
    其中,X1和X2各自独立地选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,所述步骤(1)的硼化试剂选自于联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100033
    Figure PCTCN2015089820-appb-100034
    三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100035
    更优选为联硼酸频那醇酯,
    Wherein the borating agent of the step (1) is selected from the group consisting of pinacol borate,
    Figure PCTCN2015089820-appb-100033
    Figure PCTCN2015089820-appb-100034
    Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
    Figure PCTCN2015089820-appb-100035
    More preferably, it is a benzoic acid pinacol ester,
    其中,所述步骤(1)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
    其中,所述步骤(1)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾,Wherein said base in step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium,
    其中,所述步骤(2)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、 Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst of the step (2) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
    其中,所述步骤(2)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Wherein the base of the step (2) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide and lithium diisopropylamide from C 1 -C 8 . One or more of the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine Preferred is potassium acetate.
  19. 如权利要求17所述的方法,其中,所述方法还包括:式X化合物与式III化合物在钯催化剂和碱存在下进行反应制备所述式V化合物,The method of claim 17 wherein said method further comprises: reacting a compound of formula X with a compound of formula III in the presence of a palladium catalyst and a base to prepare said compound of formula V,
    Figure PCTCN2015089820-appb-100036
    Figure PCTCN2015089820-appb-100036
    其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    式III化合物优选为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(式VIII),The compound of formula III is preferably (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula VIII),
    Figure PCTCN2015089820-appb-100037
    Figure PCTCN2015089820-appb-100037
    其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
    其中,所述的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸铯,Wherein the base is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide from C 1 -C 8 One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably Barium carbonate,
    其中,所述反应的溶剂为选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组中的一种溶剂或几种溶剂的混合溶剂,Wherein, the solvent for the reaction is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, and ring. a solvent or a group of a group consisting of pentanone, hexanone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO, and NMP a solvent mixture of solvents,
    其中,式V化合物的制备在N2或Ar的保护下进行。Among them, the preparation of the compound of the formula V is carried out under the protection of N 2 or Ar.
  20. 如权利要求16所述的式VII化合物的制备方法,所述方法包括:式IX化合物与式X化合物在钯催化剂和碱存在下进行反应以制备所述式VII化合物,A process for the preparation of a compound of formula VII according to claim 16 which comprises reacting a compound of formula IX with a compound of formula X in the presence of a palladium catalyst and a base to prepare said compound of formula VII,
    Figure PCTCN2015089820-appb-100038
    Figure PCTCN2015089820-appb-100038
    其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
    其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸钠或碳酸钾,最优选为碳酸钠,Wherein the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably carbonic acid Sodium or potassium carbonate, most preferably sodium carbonate,
    其中,式IX化合物优选为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯)。Among them, the compound of the formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methylphosphonic acid bis(benzyl ester).
  21. 如权利要求20所述的方法,所述方法还包括:式III化合物和式VI化合物在催化剂、氧化剂存在下进行反应以制备所述式IX化合物,The method of claim 20, further comprising reacting a compound of formula III and a compound of formula VI in the presence of a catalyst, an oxidizing agent to produce said compound of formula IX,
    Figure PCTCN2015089820-appb-100039
    Figure PCTCN2015089820-appb-100039
    其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基,优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基,Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy-substituted benzyl group, preferably at the same time R 1 and R 2 is isopropyl or ethyl, most preferably R 1 and R 2 simultaneously isopropyl,
    其中,所述催化剂选自于1H-四氮唑或
    Figure PCTCN2015089820-appb-100040
    优选为1H-四氮唑,
    Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
    Figure PCTCN2015089820-appb-100040
    Preferred is 1H-tetrazole,
    其中,所述氧化剂选自于间氯过氧苯甲酸、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢,优选为间氯过氧苯甲酸,Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
    其中,式IX化合物优选为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯),式III化合物优选为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮。Wherein the compound of formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester), a compound of formula III Preferred is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one.
  22. 如权利要求20或21所述的方法,所述方法还包括:式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应以制备所述式X化合物,The method according to claim 20 or 21, further comprising reacting a compound of the formula IV with a borating agent in the presence of a palladium catalyst and a base to prepare the compound of the formula X,
    Figure PCTCN2015089820-appb-100041
    Figure PCTCN2015089820-appb-100041
    其中,X2选自F、Cl、Br或I,优选为Br或I,最优选为Br, Wherein X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,所述硼化试剂选自于联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100042
    Figure PCTCN2015089820-appb-100043
    三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100044
    更优选为联硼酸频那醇酯,
    Wherein the borating agent is selected from the group consisting of pinacol borate,
    Figure PCTCN2015089820-appb-100042
    Figure PCTCN2015089820-appb-100043
    Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
    Figure PCTCN2015089820-appb-100044
    More preferably, it is a benzoic acid pinacol ester,
    其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
    其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Wherein the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium.
  23. 中间体式V化合物的制备方法,所述方法包括:按照如下步骤制备所述式V化合物:A process for the preparation of a compound of the formula V, which comprises: preparing the compound of the formula V according to the following procedure:
    (1)式III化合物与硼化试剂在钯催化剂和碱存在下进行反应,(1) a compound of the formula III is reacted with a borating reagent in the presence of a palladium catalyst and a base,
    (2)步骤(1)的产物与式IV化合物在钯催化剂和碱存在下进行反应,(2) the product of step (1) is reacted with a compound of formula IV in the presence of a palladium catalyst and a base,
    Figure PCTCN2015089820-appb-100045
    Figure PCTCN2015089820-appb-100045
    其中,X1和X2各自独立地选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 and X 2 are each independently selected from F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,所述步骤(1)的硼化试剂选自于联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100046
    Figure PCTCN2015089820-appb-100047
    三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100048
    更优选为联硼酸频那醇酯,
    Wherein the borating agent of the step (1) is selected from the group consisting of pinacol borate,
    Figure PCTCN2015089820-appb-100046
    Figure PCTCN2015089820-appb-100047
    Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
    Figure PCTCN2015089820-appb-100048
    More preferably, it is a benzoic acid pinacol ester,
    其中,所述步骤(1)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物, Wherein the palladium catalyst of the step (1) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
    其中,所述步骤(1)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、LDA、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾,Wherein said base in step (1) is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, LDA, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium,
    其中,所述步骤(2)的钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst of the step (2) is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd (OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane Complex,
    其中,所述步骤(2)的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。Wherein the base of the step (2) is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide and lithium diisopropylamide from C 1 -C 8 . One or more of the group consisting of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine Preferred is potassium acetate.
  24. 中间体式V化合物的制备方法,所述方法包括:式X化合物与式III化合物在钯催化剂和碱存在下进行反应制备所述式V化合物,A process for the preparation of a compound of the formula V, which comprises reacting a compound of the formula X with a compound of the formula III in the presence of a palladium catalyst and a base to prepare the compound of the formula V,
    Figure PCTCN2015089820-appb-100049
    Figure PCTCN2015089820-appb-100049
    其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    式III化合物优选为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮(式VIII),The compound of formula III is preferably (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (formula VIII),
    Figure PCTCN2015089820-appb-100050
    Figure PCTCN2015089820-appb-100050
    其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
    其中,所述的碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为碳酸铯,Wherein the base is selected from the group consisting of sodium carbonate, cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide from C 1 -C 8 One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably Barium carbonate,
    其中,所述反应的溶剂为选自于由水、C1-C8的醇、1,4-二氧六环、甲酸、乙酸、丁酸、戊酸、丙酮、丁酮、戊酮、环戊酮、己酮、环己酮、乙醚、乙酸乙酯、乙酸丁酯、四氢呋喃、乙腈、苯、甲苯、二甲苯、DMF、DMAC、DMSO和NMP所组成的组中的一种溶剂或几种溶剂的混合溶剂,Wherein, the solvent for the reaction is selected from the group consisting of water, C 1 -C 8 alcohol, 1,4-dioxane, formic acid, acetic acid, butyric acid, valeric acid, acetone, methyl ethyl ketone, pentanone, and ring. a solvent or a group of a group consisting of pentanone, hexanone, cyclohexanone, diethyl ether, ethyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, benzene, toluene, xylene, DMF, DMAC, DMSO, and NMP a solvent mixture of solvents,
    其中,式V化合物的制备在N2或Ar的保护下进行。Among them, the preparation of the compound of the formula V is carried out under the protection of N 2 or Ar.
  25. 中间体式IX化合物的制备方法,所述方法包括:式III化合物和式VI化合物在催化剂、氧化剂存在下进行反应以制备所述式IX化合物, A process for the preparation of a compound of the formula IX, which comprises reacting a compound of the formula III and a compound of the formula VI in the presence of a catalyst or an oxidizing agent to prepare the compound of the formula IX,
    Figure PCTCN2015089820-appb-100051
    Figure PCTCN2015089820-appb-100051
    其中,X1选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 1 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,R1和R2各自独立地选自甲基、乙基、丙基、异丙基、正丁基、仲丁基、异丁基或叔丁基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苯基;或者R1和R2各自独立地选自任选被卤素、C1-C4的烷基或C1-C4的烷氧基取代的苄基,优选R1和R2同时为异丙基或乙基,最优选R1和R2同时为异丙基,Wherein R 1 and R 2 are each independently selected from methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl or t-butyl; or R 1 and R 2 are each independently Selected from a phenyl group optionally substituted by halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy; or R 1 and R 2 are each independently selected from halogen, C 1 -C 4 alkyl or C 1 -C 4 alkoxy-substituted benzyl group, preferably at the same time R 1 and R 2 is isopropyl or ethyl, most preferably R 1 and R 2 simultaneously isopropyl,
    其中,所述催化剂选自于1H-四氮唑或
    Figure PCTCN2015089820-appb-100052
    优选为1H-四氮唑,
    Wherein the catalyst is selected from the group consisting of 1H-tetrazole or
    Figure PCTCN2015089820-appb-100052
    Preferred is 1H-tetrazole,
    其中,所述氧化剂选自于间氯过氧苯甲酸、双氧水、过氧乙酸、过氧苯甲酸或叔丁基过氧化氢,优选为间氯过氧苯甲酸,Wherein the oxidizing agent is selected from the group consisting of m-chloroperoxybenzoic acid, hydrogen peroxide, peracetic acid, peroxybenzoic acid or t-butyl hydroperoxide, preferably m-chloroperoxybenzoic acid.
    其中,式IX化合物优选为(R)-[3-(4-溴-3-氟苯基)-2-氧-5-噁唑烷基]甲基磷酸双(苄基酯),式III化合物优选为(5R)-3-(4-溴-3-氟苯基)-5-羟甲基噁唑烷-2-酮。Wherein the compound of formula IX is preferably (R)-[3-(4-bromo-3-fluorophenyl)-2-oxo-5-oxazolidinyl]methyl bis(benzyl ester), a compound of formula III Preferred is (5R)-3-(4-bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one.
  26. 中间体式X化合物的制备方法,所述方法包括:式IV化合物与硼化试剂在钯催化剂和碱存在下进行反应以制备所述式X化合物,A process for the preparation of an intermediate compound of formula X, which comprises reacting a compound of formula IV with a boronating reagent in the presence of a palladium catalyst and a base to prepare the compound of formula X,
    Figure PCTCN2015089820-appb-100053
    Figure PCTCN2015089820-appb-100053
    其中,X2选自F、Cl、Br或I,优选为Br或I,最优选为Br,Wherein X 2 is selected from the group consisting of F, Cl, Br or I, preferably Br or I, most preferably Br,
    其中,所述硼化试剂选自于联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100054
    Figure PCTCN2015089820-appb-100055
    三异丙基硼酸酯、三丙基硼酸酯、三甲基硼酸酯或三乙基硼酸酯,优选为联硼酸频那醇酯、
    Figure PCTCN2015089820-appb-100056
    更优选为联硼酸频那醇酯,
    Wherein the borating agent is selected from the group consisting of pinacol borate,
    Figure PCTCN2015089820-appb-100054
    Figure PCTCN2015089820-appb-100055
    Triisopropyl borate, tripropyl borate, trimethyl borate or triethyl borate, preferably boronic acid pinacol ester,
    Figure PCTCN2015089820-appb-100056
    More preferably, it is a benzoic acid pinacol ester,
    其中,所述钯催化剂选自于[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物、Pd(PPh3)4、 Pd(OAc)2、PdCl2(dppf)、Pd2(dba)3或Pd(dba)2,优选为[1,1′-双(二苯基膦)二茂铁]二氯化钯二氯甲烷络合物,Wherein the palladium catalyst is selected from the group consisting of [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex, Pd(PPh 3 ) 4 , Pd(OAc) 2 , PdCl 2 (dppf), Pd 2 (dba) 3 or Pd(dba) 2 , preferably [1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride dichloromethane complex,
    其中,所述碱选自于由C1-C8的醇钠、碳酸铯、碳酸锂、氢化钠、氨基钠、丁基锂、叔丁醇锂、二异丙基氨基锂、氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、醋酸钠、醋酸钾、碳酸氢钠、碳酸氢钾、三乙胺、二乙胺和乙二胺所组成的组中的一种或多种,优选为醋酸钾。 Wherein the base is selected from the group consisting of C 1 -C 8 sodium alkoxide, and cesium carbonate, lithium carbonate, sodium hydride, sodium amide, butyl lithium, lithium t-butoxide, lithium diisopropylamide, sodium hydroxide, One or more of the group consisting of potassium hydroxide, sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, sodium hydrogencarbonate, potassium hydrogencarbonate, triethylamine, diethylamine and ethylenediamine, preferably acetic acid Potassium.
PCT/CN2015/089820 2014-09-17 2015-09-17 Tedizolid phosphate, intermediate and preparation method thereof WO2016041505A1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CN201410476920.0 2014-09-17
CN201410476920.0A CN105418678B (en) 2014-09-17 2014-09-17 A kind of preparation method of Tedizolid Phosphate
CN201410546241.6 2014-10-15
CN201410545318.8 2014-10-15
CN201410545318.8A CN105566392B (en) 2014-10-15 2014-10-15 A kind of preparation method of bacterio protein synthetic inhibitor
CN201410546241.6A CN105503955B (en) 2014-10-15 2014-10-15 A kind of preparation method of the compound of resisting gram-positive bacteria
CN201510014000.1 2015-01-12
CN201510014000.1A CN105837633B (en) 2015-01-12 2015-01-12 A kind of preparation method of antimicrobial compound

Publications (1)

Publication Number Publication Date
WO2016041505A1 true WO2016041505A1 (en) 2016-03-24

Family

ID=55532563

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/089820 WO2016041505A1 (en) 2014-09-17 2015-09-17 Tedizolid phosphate, intermediate and preparation method thereof

Country Status (1)

Country Link
WO (1) WO2016041505A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112961186A (en) * 2021-02-04 2021-06-15 海南通用康力制药有限公司 Method for purifying tedizolid phosphate
CN113214239A (en) * 2021-04-06 2021-08-06 海南通用康力制药有限公司 Tedizolid refining process and preparation method of tedizole phosphate
US11555033B2 (en) 2020-06-18 2023-01-17 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
CN115850254A (en) * 2022-12-20 2023-03-28 山东润博生物科技有限公司 Synthetic method of sulfuryl pyraflufen

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058886A1 (en) * 2003-12-18 2005-06-30 Dong-A Pharm.Co.,Ltd. Novel oxazolidinone derivatives
WO2006038100A1 (en) * 2004-10-08 2006-04-13 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2009020616A1 (en) * 2007-08-06 2009-02-12 Micurx Pharmaceuticals, Inc. Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
WO2010042887A2 (en) * 2008-10-10 2010-04-15 Trius Therapeutics Methods for preparing oxazolidinones and compositions containing them
CN104327119A (en) * 2014-10-17 2015-02-04 苏州明锐医药科技有限公司 Preparation method of tedizolid phosphate
CN104610359A (en) * 2015-01-26 2015-05-13 成都新恒创药业有限公司 Key intermediate for preparing tedizolid phosphate, and preparation method of key intermediate

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058886A1 (en) * 2003-12-18 2005-06-30 Dong-A Pharm.Co.,Ltd. Novel oxazolidinone derivatives
WO2006038100A1 (en) * 2004-10-08 2006-04-13 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2009020616A1 (en) * 2007-08-06 2009-02-12 Micurx Pharmaceuticals, Inc. Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
WO2010042887A2 (en) * 2008-10-10 2010-04-15 Trius Therapeutics Methods for preparing oxazolidinones and compositions containing them
CN104327119A (en) * 2014-10-17 2015-02-04 苏州明锐医药科技有限公司 Preparation method of tedizolid phosphate
CN104610359A (en) * 2015-01-26 2015-05-13 成都新恒创药业有限公司 Key intermediate for preparing tedizolid phosphate, and preparation method of key intermediate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WEON BIN IM ET AL.: "Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 46, 18 January 2011 (2011-01-18), pages 1027 - 1039, XP028185750, DOI: doi:10.1016/j.ejmech.2011.01.014 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11555033B2 (en) 2020-06-18 2023-01-17 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
US11566023B2 (en) 2020-06-18 2023-01-31 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
CN112961186A (en) * 2021-02-04 2021-06-15 海南通用康力制药有限公司 Method for purifying tedizolid phosphate
WO2022166022A1 (en) * 2021-02-04 2022-08-11 海南通用康力制药有限公司 Purification method for tedizolid phosphate
CN113214239A (en) * 2021-04-06 2021-08-06 海南通用康力制药有限公司 Tedizolid refining process and preparation method of tedizole phosphate
CN113214239B (en) * 2021-04-06 2023-04-07 海南通用康力制药有限公司 Tedizolid refining process and preparation method of tedizole phosphate
CN115850254A (en) * 2022-12-20 2023-03-28 山东润博生物科技有限公司 Synthetic method of sulfuryl pyraflufen

Similar Documents

Publication Publication Date Title
JP2021518338A (en) Bicyclic compounds as inhibitors of PD1 / PD-L1 interaction / activation
Zhu et al. Metal-free oxidative hydrophosphinylation of 1, 7-enynes
WO2016041505A1 (en) Tedizolid phosphate, intermediate and preparation method thereof
WO2016058467A1 (en) Method for preparing tedizolid phosphate
US8946418B1 (en) Chiral nitrogen-phosphorus ligands and their use for asymmetric hydrogenation of alkenes
CN107759623B (en) Intermediate of JAK inhibitor and preparation method thereof
CN108912171B (en) Synthesis method of 4-dimethylaminobenzoyl diphenylphosphine or 4-di-n-hexylaminobenzoyl diphenylphosphine
EP3265455B1 (en) Process for preparing ceritinib and intermediates thereof
Chen et al. Chiral cyclopalladated complex promoted asymmetric synthesis of diester-substituted P, N-ligands via stepwise hydrophosphination and hydroamination reactions
D'Onofrio et al. D-Glucosamine as a novel chiral auxiliary for the stereoselective synthesis of P-stereogenic phosphine oxides
CN105418678B (en) A kind of preparation method of Tedizolid Phosphate
ES2546487T3 (en) Procedure for the preparation of aryl- and heteroarylacetic acid derivatives
CN105566392B (en) A kind of preparation method of bacterio protein synthetic inhibitor
TW201504215A (en) Method for producing pyridazine compound
CN105837633B (en) A kind of preparation method of antimicrobial compound
CN105503955B (en) A kind of preparation method of the compound of resisting gram-positive bacteria
JP6592521B2 (en) Method for producing pyrazole derivative
JP7374533B2 (en) Novel oxazolidinone compound and method for producing the same
CN102617639A (en) Lycopene intermediate 3,7-dimethyl-1,6-octadiene-1-phosphonic acid dialkyl ester, and preparation method and application thereof
JP2014151285A (en) New optically active imidazoline-phosphoric acid catalyst and derivative thereof
JP5943387B2 (en) Novel triflon derivative and method for producing the same
CN103570754A (en) Preparation method of N-(4-(3-amino-1H-indazol-4-yl) phenyl)-N'-(2-fluoro-5-methylphenyl) urea and intermediate thereof
KR101292743B1 (en) Novel statins intermediates and method for synthesizing pitavastain, rosuvastatin, cerivastatin and fluvastatin by using statins intermediates
KR101856586B1 (en) Preparation method of 13-Bromo-10H-phenanthro[9,10-b]carbazole
JP2019196359A (en) Chemical process for preparing pyrimidine derivatives and intermediates thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15841921

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15841921

Country of ref document: EP

Kind code of ref document: A1